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1 Summary 
G protein-coupled receptors comprise a large superfamily of membrane proteins which 
transmit extracellular stimuli into intracellular responses. Adrenoceptors (AR) belong to 
the α-group of Rhodopsin-family G protein-coupled receptors. Physiological activation of 
adrenoceptors is mediated by binding of the endogenous catecholamines noradrenaline and 
adrenaline and leads to the regulation of neuronal, endocrine, cardiovascular, vegetative 
and metabolic functions. In addition to the classical activation of GPCRs by binding of 
ligands, experimental evidence has accumulated showing that GPCR activation can be 
modulated by the membrane potential. In this study adrenoceptors β1-AR and β2-AR have 
been investigated in regard to the modulation of their activity by the membrane potential. 
Both receptors couple to the stimulatory Gs protein. They were used as model receptors 
because despite increasing knowledge of voltage-dependent regulation of Gi- and Gq-
coupled receptor activity, no data has been published on the voltage-sensitivity of Gs-
coupled receptors.  
Förster resonance energy transfer (FRET)-based assays were combined with whole-cell 
patch-clamp in a voltage-clamp mode in order to monitor agonist- and voltage-dependent 
alterations in either protein conformation or protein-protein interaction. Conformational 
changes of the receptor molecule upon stimulation with catecholamines in the presence or 
absence of depolarizing steps were directly monitored using FRET-based intramolecular 
receptor fusion proteins. By means of the combination of FRET and patch-clamp, voltage-
dependence of β1-AR and to smaller extent β2-AR activation was shown to be an intrinsic 
property of these Gs-coupled receptors and was transmitted to downstream signaling. 
Receptor activity and downstream signaling decreased during depolarization. This expands 
voltage-dependent GPCRs to the group that couple to stimulatory G proteins. Voltage-
dependence of β1-AR was mainly mediated via an alteration in efficacy of either Iso or Adr 
and occurred with highest sensitivity at physiological membrane potentials. Regarding Adr 
this is a unique finding since voltage-dependence of other GPCRs activated by their 
endogenous ligands were shown to rely on alterations in ligand affinity. Agonist-specificity 
of voltage-dependence was also apparent as dopamine-induced β1-AR interaction with 
arrestin 3 was enhanced during depolarization whereas it was reduced when induced by 
adrenaline, isoprenaline, noradrenaline or dobutamine. A different binding mode of 
dopamine might be responsible for these differences.  
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The second part of this thesis focused on the molecular mechanism underlying voltage-
dependence. Mutation of a charged amino acid and a residue involved in agonist binding 
did not seem to alter voltage-dependence or only yielded inconclusive results. However, 
the introduction of an additional positive charge in the vicinity of a highly conserved 
aspartic acid in TM2 (D2.50) reduced voltage-dependence of the mutant receptor. We might 
have identified this aspartic acid as one residue of a voltage-sensor in α2A-AR but further 
experiments are required in order to corroborate this hypothesis.  
Taken together these data expand voltage-dependent GPCRs to the group coupling to 
Gs proteins. Especially in excitable tissue like the heart, which expresses voltage-
dependent β1-AR the membrane potential could fine-tune adrenoceptor signaling on a time 
scale within cardiac action potentials and in the presence of endogenous or synthetic 
catecholamines. On a molecular level we suggest a possible involvement of the highly 
conserved aspartic acid D2.50 in the detection of alterations in the membrane potential in 
α2A-AR. Whether this conclusion is also transferable to other G protein-coupled receptors 
remains to be investigated.  
 
Keywords: Förster resonance energy transfer (FRET), G protein-coupled receptor 
(GPCR), adrenoceptors, voltage-dependence, Gs protein, voltage-sensor, affinity, efficacy, 
mechanism of voltage-dependence. 
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2 Zusammenfassung 
G Protein-gekoppelte Rezeptoren bilden eine Superfamilie von Membranproteinen, die 
extrazelluläre Stimuli ins Zellinnere weiterleiten. Adrenozeptoren (AR) sind G Protein-
gekoppelte Rezeptoren (GPCRs), die der α-Untergruppe der Rhodopsin-Familie 
angehören. Die endogenen Katecholamine Noradrenalin und Adrenalin führen über die 
Aktivierung von Adrenozeptoren zur Regulation verschiedenster neuronaler, endokriner, 
kardiovaskulärer, vegetativer und metabolischer Funktionen. Zusätzlich zur klassischen 
Aktivierung von GPCRs durch Agonistenbindung an einen Rezeptor konnte die Regulation 
der Aktivität durch eine Veränderung des Membranpotentials für eine Reihe Gi- und Gq-
gekoppelter Rezeptoren gezeigt werden. Zu Beginn dieser Arbeit war jedoch noch keine 
Untersuchung zur Spannungsabhängigkeit Gs-gekoppelter Rezeptoren beschrieben. 
Deshalb wurde in dieser Arbeit die Aktivität der Gs Protein-gekoppelten Adrenozeptoren 
β1-AR und β2-AR hinsichtlich ihrer Modulation durch das Membranpotential untersucht.  
Die Kombination Förster-Resonanz-Energie-Transfer (FRET)-basierter Messungen und 
der patch-clamp Methode im voltage-clamp Modus ermöglichte die Aufzeichnung agonist- 
und spannungsabhängiger Änderungen von Proteinkonformationen oder von Protein-
Protein-Wechselwirkungen. Es wurden intramolekulare FRET-basierte Rezeptor-
Fusionsproteine eingesetzt, um den Einfluss des Membranpotentials auf Bewegungen im 
aktivierten Rezeptormolekül direkt zu untersuchen. Für die Untersuchung von Protein-
Protein-Wechselwirkungen kamen intermolekulare FRET-Sensoren zum Einsatz.  
Mithilfe der Kombination aus FRET und elektrophysiologischen Messungen konnte in 
dieser Arbeit die Spannungsabhängigkeit des β1-AR gezeigt werden, die sich in einer 
Aktivitätsabnahme bei Depolarisation äußerte. Auch der eng verwandte β2-AR zeigte eine 
depolarisationsabhängige Abnahme der Aktivität, jedoch war diese schwächer ausgeprägt 
als bei β1-AR. Die Spannungsabhängigkeit übertrug sich für beide Rezeptoren auch auf die 
nachgeschaltete Signalkaskade. Diese Ergebnisse erweitern den Kreis 
spannungsabhängiger Rezeptoren um die Gruppe Gs-gekoppelter Rezeptoren. 
Im Falle des β1-AR wurde die Spannungsabhängigkeit hauptsächlich über eine 
Änderung der intrinsischen Aktivität der Agonisten Isoprenalin und Adrenalin vermittelt. 
Dies ist erstaunlich, da bisher die Spannungsabhängigkeit von Rezeptoren, die durch 
endogene Agonisten aktiviert wurden, nur eine Regulation der Agonistaffinität bekannt 
war. Es konnte ebenfalls eine agonistspezifische Komponente der β1-AR 
Spannungsabhängigkeit ermittelt werden: Mit Dopamin aktivierte Rezeptoren zeigten eine 
Zunahme ihrer Aktivität während der Depolarisation während die Isoprenalin-, 
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Noradrenalin-, Adrenalin- und Dobutamin-vermittelte Aktivität bei positiven 
Membranpotentialen abnahm. Der entgegengesetzten Spannungsabhängigkeit von 
Dopamin-aktivierten Rezeptoren könnte ein geändertes Bindungsverhalten von Dopamin 
in der Rezeptorbindetasche zugrunde liegen.  
Der zweite Teil dieser Arbeit beschäftigt sich mit der Untersuchung des molekularen 
Mechanismus, der der Spannungsabhängigkeit zugrunde liegt. Hierfür wurden 
verschiedene Aminosäuren im spannungsabhängigen α2A-AR mutiert. Die Neutralisation 
einer geladenen Aminosäure und der Änderung einer Aminosäure, die an der 
Agonistbindung beteiligt ist, schienen die Spannungsabhängigkeit nicht zu beeinflussen. 
Jedoch führte das Einbringen einer zusätzlichen, positiven Ladung in die Nähe des 
hochkonservierten Aspartats D2.50 in TM2 zu einer Reduktion der Spannungsabhängigkeit. 
Diese Aminosäure könnte eine Komponente des Spannungssensors des α2A-AR sein, 
jedoch sind weitere Experimente nötig, um diese Hypothese zu untermauern.  
Zusammengefasst erweitern die in dieser Arbeit vorgestellten Daten die Gruppe der 
spannungsabhängigen GPCR um jene, die ihr Signal über stimulatorische Gs-Proteine 
vermitteln. Besonders in erregbaren Geweben wie dem Herzen, das β1-AR exprimiert, 
könnte das Membranpotential für eine zusätzliche Feinregulation der Rezeptoraktivität 
sorgen. Dies könnte sich im zeitlichen Rahmen kardialer Aktionspotentiale abspielen und 
ohne die Dissoziation des Agonisten vor sich gehen. Auf molekularer Ebene ist eine 
Beteiligung des hochkonservierten Aspartats in TM2 (D2.50) an der Erkennung von 
Spannungsänderungen der Plasmamembran im α2A-AR denkbar. Ob sich dies auch auf 
andere spannungsabhängige GPCRs übertragen lässt, bleibt zu ermitteln.  
 
Stichworte: Försterresonanzenergietransfer (FRET), G Protein-gekoppelte Rezeptoren, 
Adrenozeptoren, Spannungsabhängigkeit, Gs Protein, Spannungssensor, intrinsische 
Aktivität, Affinität, Mechanismus der Spannungsabhängigkeit. 
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3 Introduction 
A plasma membrane surrounds all living cells and separates the cytoplasm from the 
extracellular environment. It is a bilayer formed by amphiphilic phospholipids and 
embedded proteins and acts as a barrier for charged molecules. Different concentrations of 
ions within the cell or the extracellular space separated by the plasma membrane cause a 
gradient. Electrodiffusion along this gradient leads to a charge separation and to the 
generation of the membrane potential. The strong electrical field that arises from the 
charge separation across the very thin plasma membrane can be used by membrane 
proteins to generate their functions or to allosterically alter their function. Voltage-gated 
ion channels are prototypical for membrane proteins whose activity is regulated by the 
membrane potential. A stretch of basic amino acids in one transmembrane (TM) domain of 
each subunit moves through the membrane upon alterations in its potential causing 
conformational changes in the ion channel molecule. The membrane potential also 
influences the activity of voltage-dependent phosphatases or of some ion carriers and 
pumps (Molleman, 2003; Bezanilla, 2008). Within the last 12 years evidence has 
accumulated that also the activity of agonist-occupied G protein-coupled receptors 
(GPCRs) can be modulated by the membrane potential (VM). This voltage-dependence of 
GPCRs, using the example of adrenoceptors (ARs), will be the topic of this study. 
3.1 G protein-coupled receptors  
The human genome encodes for over 800 different G protein-coupled receptors which 
are phylogenetically divided into five different receptor families with several subgroups: 
The Rhodopsin-, the Secretin-, the Glutamate-, the Adhesion- and the Frizzled/TAS2-
receptor families (Takeda et al., 2002; Fredriksson et al., 2003; Katritch et al., 2013). A 
diversity of ligands including amines, peptides, glycoproteins, ions and proteases as well as 
exogenous stimuli like light or organic odors are able to activate GPCRs leading to GPCR-
mediated cellular responses (Takeda et al., 2002; Fredriksson et al., 2003). As GPCRs 
control a variety of signal transduction processes in the human body they are targets for 
about 36% of drugs listed in the DrugBank (Rask-Andersen et al., 2011). 
Biochemical and theoretical studies as well as a low resolution projection map of 
rhodopsin suggested common structural features for GPCRs (Baldwin, 1994). 15 years ago 
the crystal structure of bovine rhodopsin was solved and a few years later solved again 
with higher resolution (Palczewski, 2000; Li et al., 2004; Okada et al., 2004). Since then 
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technological progress enabled the crystallization of more GPCRs in both active and 
inactive states ((Tate and Schertler, 2009) reviewed in (Katritch et al., 2013)). 
 
Figure 1: Inactive and active state crystal structures of the β2-adrenoceptor. 
The active (green) and inactive (blue) structures of an engineered β2-adrenoceptor are overlaid in their side 
views and show the seven transmembrane helices and parts of the extra- and intracellular loops. The active 
structure was obtained as a ternary complex of the agonist-bound receptor and the nucleotide-free Gs protein 
heterotrimer. The inactive structure was obtained in the presence of carazolol (Cz). The ligand is shown as 
yellow spheres. Activation-dependent structural changes are most prominent in the intracellular parts of 
transmembrane domains five and six (Rasmussen et al., 2011a). 
These crystal structures confirmed that GPCRs share a common structure of seven 
transmembrane α-helices, connected by intra- and extracellular loops of variable length, an 
extracellular amino and an intracellular carboxyl terminus (Figure 1). Because of the seven 
TM bundle, GPCRs are also referred to as 7-TM or heptahelical receptors (Huber et al., 
2008). Although GPCRs share this common structure, the overall sequence homology is 
low (Gether, 2000).  
3.1.1 G protein coupled receptors transduce extracellular stimuli into intracellular 
signals 
Activation of GPCRs and further signal transduction is a multistep process which is 
initiated by the binding of a ligand to the receptor or induced by photons in case of 
rhodopsin. An orthosteric ligand binding pocket is located inside the TM-bundle in most 
GPCRs whereas others bind there ligands at their amino termini (Baldwin, 1994; 
Fredriksson et al., 2003). Ligand binding to the receptor initiates conformational changes 
in the receptor molecule starting at the ligand binding site and expanding via the 
transmembrane helices with several conformational intermediates (Kobilka and Deupi, 
2007; Hofmann et al., 2009). The most prominent transmembrane movements seen 
between crystal structures of the inactive β2-AR and active β2-AR in complex with the Gs 
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protein are an outward movement of TM6 and an extension of the cytoplasmic end of TM5 
(Figure 1).  
Movements of TM5 and TM6 open a cleft on the cytosolic side of the receptor in which 
the Gα-subunit’s carboxyl terminus can interact with its binding moieties (Figure 2, 
(Rasmussen et al., 2011a)). The conformational changes and intermediates, however, vary 
between receptors and can also vary within one receptor when activated by different 
ligands (Kobilka and Deupi, 2007). In a ternary complex consisting of the agonist, the 
receptor and the G protein, the receptor is stabilized in its fully activated state (Rasmussen 
et al., 2011b). 
 
Figure 2: The ternary complex of an agonist-occupied β2-adrenoceptor and a stimulatory G protein. 
The agonist-activated β2-AR (agonist: yellow spheres, receptor: green) is shown in complex with the 
stimulatory Gs protein with its α- (orange), β- (cyan) and γ- (purple) subunits (modified from (Rasmussen et 
al., 2011a)). 
3.1.1.1 The G protein cycle 
Upon activation of a GPCR by a ligand, membrane-bound heterotrimeric G proteins are 
recruited to the receptor (Figure 3). These heterotrimeric G proteins consist of a Gα-, a Gβ- 
and a Gγ-subunit and so far 23 different Gα-, 5 Gβ- and 14 Gγ-subunits have been 
identified in humans. Gα-subunits are divided into the four long known classes Gαs, Gαi, 
Gαq and Gα12 based on sequence homology and are further subdivided into 2-4 groups 
each. Gβ and Gγ solely function as heterodimers and the dimer will be referred to as βγ-
subunit or simply βγ. Due to the number of different Gβ- and Gγ-subunits many functional 
dimer combinations can be formed (Simon et al., 1991; McCudden et al., 2005; Milligan 
and Kostenis, 2006; Oldham and Hamm, 2008).  
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Figure 3: The G protein cycle. 
The schematic shows different steps of the G protein cycle. Binding of a ligand (red diamond) to a receptor 
induces interaction of the heterotrimeric G protein (βγ is represented as one gray sphere only) with the 
activated receptors. The activated G protein dissociates from the receptor upon nucleotide exchange and an 
activating conformational change (depicted as a rearrangement of the α- and βγ-subunits). The α- and βγ-
subunits interact with effectors (gray pentagon, E) upon activation. Hydrolysis of GTP by the α-subunit’s 
GTPase activity terminates the G protein cycle.  
Activated GPCRs serve as a guanine nucleotide exchange factor (GEF): They facilitate 
the exchange of GDP to GTP in the associated G protein by favoring a conformational 
change in the Gα-subunit’s Ras domain which leads to G protein activation and 
dissociation from the receptor (Figure 3, (Tuteja, 2009; Dror et al., 2015)). The nucleotide 
exchange in the Gα-subunit marks the rate-limiting step of G protein-mediated signaling 
(Oldham and Hamm, 2007). A conformational change within the G protein, induced by the 
nucleotide exchange, was believed to cause dissociation of the GTP-bound Gα from the 
constitutive heterodimeric βγ-subunit (Hofmann et al., 2009). However, for the Gi protein a 
conformational rearrangement of the subunits upon activation rather than their dissociation 
has been described. In Förster resonance energy transfer (FRET)-based assays monitoring 
Gi protein activation an increase in FRET was detected upon receptor stimulation. If the 
subunits dissociated from each other, FRET would have decreased due to an increasing 
distance between the donor and acceptor fluorophore (5.3.3.1, (Bünemann et al., 2003)). 
Similar findings were observed in measurements that relied on bioluminescence resonance 
energy transfer (BRET) (Galés et al., 2006). A conserved region in the α-helical domain of 
Gi protein subtypes seemed to be required for the activation-dependent increase in FRET 
between fluorescently labeled Gαi and Gβγ-subunits (Frank et al., 2005). A decrease in 
FRET between fluorescently labeled α and βγ of the Gs protein upon receptor stimulation 
does not necessarily point towards subunit dissociation but could also result from a 
structural rearrangement leading to fluorophore orientations which do not favor energy 
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transfer (Hein et al., 2006) A dissociation of the subunits can be induced by binding of 
G protein effectors to the heterotrimeric complex (Figure 3, personal communication with 
Dr. Eva-Lisa Bodmann and Anna-Lena Krett and (Wolters, 2014)).  
Upon G protein activation both α- and βγ-subunits transfer the signal to distinct 
intracellular effectors like enzymes or ion channels which in turn modulate diverse 
signaling pathways for example via the generation of second messengers. The G protein 
cycle is completed with the hydrolysis of GTP to GDP by the inherent GTPase activity of 
the Gα-subunit and the subsequent reassociation or deactivating rearrangement of the 
subunits (Figure 3, reviewed in (Wettschureck and Offermanns, 2005; Milligan and 
Kostenis, 2006; Oldham and Hamm, 2008; Reiter et al., 2012)). In addition to signaling via 
GPCRs located at the plasma membrane, a second phase of G protein-dependent signaling 
was suggested to arise from internalized GPCRs located on early endosomes (Irannejad et 
al., 2013).  
Besides signaling through G proteins, several other protein families can also interact 
with activated GPCRs in a G protein-independent way. These include for example PDZ 
domain-containing proteins (Bockaert et al., 2004), non-receptor and receptor tyrosine 
kinases (Marrero et al., 1995; Sun et al., 2007), G protein-coupled receptor kinases (GRKs) 
and arrestins (Arr) (Pierce et al., 2002; Reiter et al., 2012). A large variety of allosteric 
modulators like ions, lipids, some drugs or the membrane potential can additionally alter 
GPCR activity and signaling (Christopoulos, 2002; Ben-Chaim et al., 2003; Katritch et al., 
2014). 
3.1.2 G protein-coupled receptor homologous desensitization and internalization is 
mediated by G protein-coupled receptor kinases and arrestins 
GPCR-mediated signaling needs to be tightly regulated in order to maintain proper cell 
function. Apart from the recruitment of G proteins, activated GPCRs also represent targets 
for GRKs which phosphorylate serine and threonine residues in the C-terminus of GPCRs 
as a first step of homologous desensitization, i.e. desensitization of agonist-occupied 
receptors (Figure 4, (Pierce and Lefkowitz, 2001; Pierce et al., 2002; Krasel et al., 2005)). 
However, a new study has also described phosphorylation of unstimulated GPCRs by 
GRKs of the GRK4 family (Li et al., 2015). A second form of desensitization, the 
heterologous desensitization, which occurs independently of agonist occupancy of the 
receptor, is induced by protein kinase A (PKA)- and protein kinase C (PKC)-mediated 
receptor phosphorylation (Pierce and Lefkowitz, 2001) but will not be described in detail 
here.  
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Figure 4: G protein-coupled receptor homologous desensitization and internalization. 
Members of the G protein-coupled receptor kinase 2 family (gray hexagon) phosphorylate agonist-occupied 
receptors. Arrestins translocate to agonist-activated and phosphorylated receptors and the complex 
accumulates in clathrin-coated pits (clathrin: gray, Y-shaped). Arrestin dissociates from internalized 
receptors or only transiently interacts with receptors at the plasma membrane. Receptors are either 
dephosphorylated and cycle back to the membrane or will be degraded in lysosomes.  
3.1.2.1 G protein-coupled receptor kinases 
GRKs are a family of serine/threonine kinases with seven members (GRK1-7). The 
expression of GRK1 and 7 is restricted to the retina and GRK4 is mainly expressed in the 
brain, kidneys and testes. GRK2, GRK3, GRK5 and GRK6, in contrast, are ubiquitously 
expressed (Pierce et al., 2002; Shenoy and Lefkowitz, 2003). The GRK subtypes also 
differ in their localization within the cell. GRK2, GRK3 and GRK5 are cytosolic proteins. 
Translocation to the membrane of GRK2 and GRK3 is facilitated by the binding of the βγ-
subunit of G proteins to the GRK’s c-terminal PH-domain. The membrane association of 
GRK5, in contrast, is promoted by phosphatidylinositol 4,5-bisphosphate (PIP2). A 
constant tethering to the plasma membrane of GRK1, GRK7, GRK4 and GRK6 is 
achieved by farnesylation of the first two and palmitoylation of the latter two GRK 
subtypes (Pitcher et al., 1992, 1996; Stoffel et al., 1994; Shenoy and Lefkowitz, 2003). 
Phosphorylation of GPCRs by GRKs as a first step of desensitization was described to be 
strictly activation-dependent (Gurevich et al., 2012). Interaction of GRK2 with active β2-
AR activates GRK2 which makes activated β2-ARs targets for and allosteric activators of 
GRKs (Chen et al., 1993). Strict activation-dependent phosphorylation was shown for 
GRK2 and GRK3 (Benovic et al., 1987; Krasel et al., 2005; Li et al., 2015). However, 
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GRK5 and GRK6 of the GRK4 family also phosphorylated unstimulated receptors which 
resulted in arrestin recruitment to the inactive but phosphorylated receptors (Li et al., 
2015). Desensitization by GRKs can also occur in a phosphorylation-independent manner 
as shown for the metabotropic glutamate receptor (mGluR) type 5 in neurons (Ribeiro et 
al., 2009).  
3.1.2.2 Arrestins 
GRK-mediated receptor phosphorylation is then followed by the second step of 
homologous desensitization: The translocation of arrestins from the cytosol to the 
membrane and their interaction with the phosphorylated receptor (Figure 4, (Barak et al., 
1997; Shenoy and Lefkowitz, 2005)). Activation of the receptors and phosphorylation of 
agonist-occupied receptors by GRKs of the GRK2 family is required for high affinity 
arrestin binding to the receptor (Krasel et al., 2005; Violin et al., 2006). In a FRET-based 
assay monitoring β2-AR interaction with arrestin 3, functional GRK2 was necessary in 
order to detect an increase in FRET, i.e. to induce receptor-arrestin interaction. Expression 
of a dominant negative form of GRK2 abolished the agonist-evoked FRET signal observed 
in the presence of functional GRK2 (Krasel et al., 2005).  
Arrestins form a small family of four proteins, two of which are expressed ubiquitously 
(Arr 2 and Arr 3) whereas Arr 1 and Arr 4 are considered visual arrestins and localize to 
rods and cones, respectively. Arrestins terminate G protein-mediated signaling by sterically 
hindering G protein-receptor interaction, they induce signaling for example via Src-family 
kinases and initiate internalization of most GPCRs via clathrin-coated pits (CCPs) (Luttrell 
et al., 1999; Krasel et al., 2005; Shenoy and Lefkowitz, 2005). With a binding motif for 
clathrin near the arrestin C-terminus, arrestins can directly interact with the clathrin heavy 
chain (Goodman et al., 1996; Krupnick et al., 1997). In addition direct interaction with the 
clathrin-adapter protein 2 (AP2) has also been shown and is also required for arrestin-
mediated endocytosis. Arrestins therefore directly link (ligand-activated) phosphorylated 
receptors to the internalization machinery to induce clathrin-mediated endocytosis. 
Endocytosis can then lead to receptor resensitization and recycling back to the plasma 
membrane or to lysosomal degradation (Figure 4, (Laporte et al., 1999, 2000; Ferguson, 
2001; Shenoy and Lefkowitz, 2003; Ribas et al., 2007)). 
3.1.3 Adrenoceptors 
Adrenoceptors are GPCRs physiologically activated by the endogenous ligands 
noradrenaline and adrenaline and belong to the α-group of the Rhodopsin-family, which is 
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the largest family of GPCRs with about 670 members (Fredriksson et al., 2003). Based on 
their physiologic actions, on anatomical grounds and, later, on molecular cloning of the 
receptors, adrenoceptors were subdivided into three α1-ARs, three α2-ARs and three β-
ARs. Adrenoceptors regulate a variety of functions in the neuronal, endocrine, 
cardiovascular, vegetative system. Single nucleotide polymorphisms (SNPs) in the genes 
for different subtypes can result in variations in receptor function and responsiveness to 
medical treatment among individuals (Kirstein and Insel, 2004; Hein, 2006; Ahles and 
Engelhardt, 2014). The adrenoceptors α2A-AR, β1-AR and β2-AR were used in this study to 
investigate the voltage-dependent regulation of receptor activity.  
3.1.3.1 α2A-adrenoceptors 
Activation of α2-ARs induces coupling of Gi-proteins to the receptors’ third intracellular 
loop resulting in their activation. A decrease in cyclic adenosine monophosphate (cAMP) 
concentration through the inhibition of adenylyl cyclases (ACs) via the Gαi-subunit 
follows G protein activation. The βγ-subunit in turn inhibits voltage-gated Ca2+-channels 
and activates GIRK-channels. Additionally, activation of signaling via mitogen-activated 
protein (MAP) kinases and phospholipases has been shown (Docherty, 1998; Saunders and 
Limbird, 1999; Hein, 2006). α2-ARs are involved in the regulation of, for example, 
neurotransmitter release, platelet aggregation or blood pressure (Knaus et al., 2007). The 
subtype A of α2-ARs (α2A-ARs) is found pre-and postsynaptically in the peripheral and 
central nervous system as well as in non-neuronal tissue. Presynaptic α2A-ARs in 
sympathetic nerves control neurotransmitter release and thereby regulate the sympathetic 
innervation of the heart and of noradrenergic neurons in the central nervous system (CNS). 
They are also involved in the regulation of vascular smooth muscle cell contraction but 
central effects predominate (Docherty, 1998; Hein et al., 1999).  
An extensive study has elaborated on the voltage-dependence of α2A-ARs, which is an 
intrinsic property of the receptor molecule and independent of Gi protein binding (Rinne et 
al., 2013). In the present thesis, the α2A-AR has been used to further investigate the 
molecular mechanism of GPCR voltage-dependence by site-directed mutagenesis.  
3.1.3.2 β1- and β2-adrenoceptors 
β-adrenoceptors regulate many physiological processes in the cardiovascular system, 
the airways, the uterine system and the peripheral metabolism. Receptor activation 
increases, for example, the heart rate and contractility (β1-AR) or leads to the relaxation of 
smooth muscle cells (β2-AR) (Kirstein and Insel, 2004; Hein, 2006) which makes them 
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important targets in the treatment of cardiovascular diseases or asthma, respectively 
(Frishman, 2013; Ortega, 2014). Both β1-AR and β2-AR have also been found to be 
expressed in the brain were they are involved in the retrieval of memory, the control of 
melanin circadian rhythm and the central regulation of the sympathetic tone (Hein, 2006). 
The third β-AR isoform, β3-adrenoceptors, will not be discussed here.  
In contrast to α2-ARs, β-adrenoceptors couple to stimulatory Gs proteins which induce 
cAMP production via the stimulation of ACs. In cardiomyocytes, elevated cAMP-levels 
activate PKA which phosphorylates various effectors like L-type Ca2+-channels and 
sarcoplasmic reticulum-located ryanodine receptors which ultimately increases the 
intracellular Ca2+ concentration. β-ARs themselves are also targets of PKA and desensitize 
upon PKA phosphorylation (Lymperopoulos et al., 2013). 
3.2 Voltage-dependence of G protein-coupled receptors 
The regulation of GPCR activity by the membrane potential has gained increasing 
interest since the first documentations of voltage-regulation of muscarinic acetylcholine 
(ACh) receptor 2 (M2AChR) activity in 2003 (Ben-Chaim et al., 2003). Since then several 
other GPCRs of the Rhodopsin- and Glutamate-receptor family have been shown to be 
voltage-dependent. Voltage-dependence is transmitted from the receptor molecule to 
downstream signaling which was detected as altered G protein-activated inwardly 
rectifying channel (GIRK) activation, Ca2+ signaling, G protein activation or receptor-
arrestin interaction (for example (Martinez-Pinna et al., 2004; Sahlholm et al., 2012; Rinne 
et al., 2013)). 
Two important parameters have to be considered when describing the pharmacology of 
a drug: Its affinity and efficacy. The affinity is a measure of how well a substance binds to 
its molecular target, in this study its receptor. Efficacy describes how well this substance is 
able to induce a biological response through binding to its target (Huber et al., 2008). The 
intrinsic efficacy describes the direct effect of a compound on the receptor molecule itself, 
i.e. its ability to activate the receptor (Kenakin, 1984). Regulation of receptor activity by 
the membrane potential could be achieved through alterations in efficacy and/or affinity. 
Both has been demonstrated indirectly or directly for several GPCRs. Depolarization-
dependent effects on efficacy have been suggested for purinergic P2Y1 receptors (P2Y1R), 
muscarinic M2 acetylcholine receptors (M2AChR) stimulated with pilocarpine and 
dopaminergic D2 receptors (D2R) (Gurung et al., 2008; Navarro-Polanco et al., 2011; 
Sahlholm et al., 2011). However, direct evidence for a reduction in efficacy during 
depolarization has only been published for clonidine-activated α2A-ARs (Rinne et al., 
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2013). Potentiation of Ca2+ signaling at depolarization not only occurred during P2Y1R 
stimulation with adenosine diphosphate (ADP) but also in the presence of competitive 
antagonists (Gurung et al., 2008). Ca2+ signaling evoked by stimulation of the 
lysophosphatidic acid (LPA) receptor was also potentiated during depolarization 
(Martinez-Pinna et al., 2010). Agonist binding was increased during depolarization at the 
muscarinic M1AChR and the mGluR1 while it was decreased at M2AChR and mGluR3 
(Ben-Chaim et al., 2003; Ohana et al., 2006). A decrease in agonist affinity was also 
determined to underlie voltage-dependence of noradrenaline-stimulated α2A-AR using a 
FRET-based intramolecular fusion protein of this receptor (α2A-AR-cam, (Vilardaga et al., 
2003; Rinne et al., 2013)). A minor right shift in concentration-response curves for 
histamine-induced GIRK activation via H3R and less pronounced via H4 at depolarization 
indicated voltage-sensitivity of these receptors as well (Sahlholm et al., 2012). In addition 
to alterations in affinity/efficacy also an agonist-specific voltage-sensitivity was present at 
M2AChR, H4R, at the short splice-variant of D2R (D2SR), at α2A-AR and, as will be seen in 
this study, at the β1-AR (Navarro-Polanco et al., 2011; Sahlholm et al., 2011, 2012; Rinne 
et al., 2013; Birk et al., 2015). So far only few GPCRs have been identified which lack 
detectable voltage-dependence. To my knowledge these are the dopamine D3 receptor 
(Sahlholm et al., 2008a) and the adenosine A2A receptor (A2AR) (personal communication 
with Prof. Bünemann and Prof. Rinne).  
In voltage-gated ion channels gating currents arise from the movement of a voltage-
sensor upon alterations in the membrane potential. This voltage-sensor is located in the 
fourth transmembrane segment (S4) and is comprised of positively charged, basic amino 
acids (Aggarwal and MacKinnon, 1996; Seoh et al., 1996). Movement of the charged 
segment upon alterations in the membrane potential translates into a conformational 
change in the ion channel thereby changing channel conductance and open probability. 
Other mechanisms by which membrane proteins could react to altered potentials with a 
conformational change include movement of ions localized in cavities within the proteins 
or reorientation of dipole-containing residues (Bezanilla, 2000, 2008). An important 
finding in the research of voltage-dependence of GPCRs was the detection of gating 
currents in M2AChR (Ben-Chaim et al., 2006). Measurements of gating currents in 
M2AChR and of voltage-dependent conformational changes in the α2A-AR-cam suggested 
that voltage-dependence is an intrinsic property of the receptor molecule (Ben-Chaim et 
al., 2006; Navarro-Polanco et al., 2011; Rinne et al., 2013). This was also supported by a 
close correlation between depolarization-induced charge movement (gating charges) and 
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agonist binding to M2AChR. Voltage-dependent conformational changes in the binding 
pocket of this receptor detected by site-directed fluorescence labeling also correlated well 
with charge movement and suggested voltage-dependence to reside at the receptor level 
(Dekel et al., 2012). However, a similar structure to the S4-segment or other structures 
which could function as a voltage-sensor are not obviously present in GPCRs (Bezanilla, 
2008). Therefore the mechanism by which GPCRs sense alterations in the membrane 
potential remains unclear. 
3.2.1 The mechanism of voltage-dependence of G protein-coupled receptors  
Since the publication of first experimental evidence for a voltage-dependent regulation 
of GPCR activity, it was the aim to elucidate the underlying mechanism. The mode of 
agonist binding within the binding pocket of GPCRs was recently shown to effect direction 
of voltage-dependence of muscarinic receptors. Interaction with an asparagine residue in 
TM6 determined whether receptor activation was enhance or reduced during depolarization 
(Rinne et al., 2015). Gating currents measured in the M2AChR pointed to the existence of a 
voltage-sensor which is, most likely, charged or is at least expected to contain (a) dipole(s) 
(Bezanilla, 2000; Ben-Chaim et al., 2006; Navarro-Polanco et al., 2011). In the 
prototypical voltage-gated Shaker K+ channel the voltage-sensor consists of a segment 
containing several basic amino acids. The amount of charge moved per channel was 
calculated to be 13 e0, which causes a steep voltage-dependence of these channels 
(Bezanilla, 2008). Compared to voltage-gated ion channels the steepness of GPCR voltage-
sensitivity is shallower. Current-voltage relations or FRET response-voltage relations 
yielded similar numbers of charges moved across the membrane: z=0.76 e0 in M1AChR,, 
z=0.55 or 0.85 e0 in M2AChR, and z=0.5 e0 in α2A-AR (Ben-Chaim et al., 2006; Navarro-
Polanco et al., 2011; Rinne et al., 2013, 2015). Voltage-dependence resided within the 
range of physiological membrane potentials with a half maximal effective potential (V50) 
of V50=-53 mV (M1AChR, (Rinne et al., 2015)), V50=-44 mV or -67 mV (M2AChR,  (Ben-
Chaim et al., 2006; Navarro-Polanco et al., 2011)) and V50=-20 mV (α2A-AR, (Rinne et al., 
2013)). In order to sense alterations in the membrane potential it is also likely that the 
voltage-sensor would reside within the transmembrane region where the electrical field is 
strongest. Using mutational studies research groups set off to identify (residues of) the 
GPCR voltage-sensor.  
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3.2.1.1 Mutation of a conserved motif and charged amino acids 
Site-directed mutagenesis has been performed of conserved micro domains or charged 
amino acids conserved among Rhodopsin-family GPCRs within the TM domains or in 
receptor sections close to the plasma membrane. In the muscarinic M2AChR, the most 
studied GPCR in terms of voltage-sensitivity, several mutations have been inserted. An 
early study suggested that the DRY-motif in TM3, which is highly conserved among 
Rhodopsin-family GPCRs, would be (part of) the voltage sensor (Gether, 2000; Ben-
Chaim et al., 2006). Residues of the DRY-motif are involved in the so called ionic lock 
through ionic bonds with a glutamate and threonine in TM6 which stabilizes GPCRs in 
their inactive state. Mutations of the ionic lock residues increases basal activity of many 
GPCRs (Palczewski, 2000; Kobilka and Deupi, 2007). Mutation of the charged aspartic 
acid and arginine residues of the DRY-motif to asparagine (NNY-mutant) diminished 
gating charges and voltage-dependent radioligand binding (Ben-Chaim et al., 2006). 
However, a later study could not reproduce these findings and showed gating currents also 
in the NNY-mutant (Navarro-Polanco et al., 2011). Mutation of the corresponding amino 
acids in the α2A-AR did not abolish voltage-sensitivity in this receptor either (unpublished 
data). A charge-neutralizing mutation of a glutamate in TM6 (E6.30A) involved in the ionic 
lock in dopamine D2 receptors did not remove or alter the receptors’ voltage-dependence, 
neither did a corresponding mutation (D6.30A) in histamine H3 receptors (Sahlholm et al., 
2012). This argued against an involvement of these conserved and/or charged amino acids 
in the GPCR voltage-sensing process. 
3.2.1.2 Mutation of amino acids involved in sodium coordination 
Crystal structures of β1-AR and the A2A revealed a binding site for a sodium ion which 
is coordinated by amino acids highly conserved among the Rhodopsin-family GPCRs, 
namely D2.50 and S3.39 (Ballesteros-Weinstein numbering in superscript (Ballesteros and 
Weinstein, 1995)), together with three structural water molecules (Mirzadegan et al., 2003; 
Liu et al., 2012; Gutiérrez-De-Terán et al., 2013; Miller-Gallacher et al., 2014). In 
addition, the also highly conserved amino acids N1.50, W6.48, N7.45, N7.49 and Y7.53 form a 
larger network of hydrogen bonds with and around the sodium coordination pocket (Liu et 
al., 2012). Several studies have addressed the allosteric modulation of agonist binding and 
receptor function by sodium ions especially in Rhodopsin-family GPCRs (reviewed in 
(Katritch et al., 2014)). Sodium binding to its binding pocket stabilizes receptors in their 
inactive state. A dramatic change of the pocket upon agonist binding might lead to the 
release of the ion to the cytoplasm which would be facilitated especially by the movement 
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of TM6 and TM7 during activation. The ionic current resulting from the sodium 
translocation could be involved in GPCR voltage-dependence and could contribute to the 
gating currents (Katritch et al., 2014). Mutation of the sodium-coordinating D2.50 to alanine 
(D2.50A) in M2AChRs greatly reduced receptor membrane expression. Therefore, the 
authors were not able to investigate an involvement of this mutant in voltage-sensing 
(Navarro-Polanco et al., 2011). The corresponding aspartic acid was mutated in the α2A-
adrenoceptor to investigate its role in voltage-dependence.  
Despite many mutagenesis studies and a lot of effort that has been put into the 
identification of a GPCR voltage-sensor, it remains unidentified. 
3.3 Aim of the study 
GPCRs comprise a large superfamily of membrane proteins whose activation by a large 
variety of extracellular stimuli translates into intracellular signaling via heterotrimeric 
G proteins or other interaction partners. Besides the ability to bind chemically diverse 
ligands, intrinsic voltage-dependence was demonstrated for several Gi- and Gq-coupled 
receptors of the Rhodopsin- and Glutamate-receptor families. The membrane potential was 
shown to alter ligand binding, activation and/or downstream signaling of receptors like 
M1/2AChR, D2R, mGluR1/3, H3/4R, α2A-AR, P2Y1 or LPA receptors. When the work for this 
study began, there have been no reports on whether also Gs-coupled receptors exhibit 
voltage-dependence. Thus, the aim of this work was to investigate voltage-dependence of 
Gs-coupled receptors using β1-AR and β2-AR as model receptors. FRET measurements in 
single living cells were combined with whole-cell patch clamp in the voltage-clamp mode 
to determine the influence of membrane potential alterations on receptor activation. With 
intramolecular FRET-based fusion proteins of both β1-AR and β2-AR I aimed to detect 
voltage-dependent conformational changes in the receptor molecules which would indicate 
an intrinsic voltage-dependence. Whether voltage-sensitivity was transmitted to 
downstream signaling was answered using FRET assays monitoring G protein activation or 
the interaction of receptors and G proteins or receptors and arrestin 3. Analysis of 
deactivation kinetics as well as of concentration-dependence of voltage-sensitivity helped 
to quantify the contribution of altered agonist affinity or efficacy to β-AR voltage-
dependence.  
The mechanism how GPCRs sense alterations in the membrane potential is unclear. 
GPCRs do not possess a similar motif to S4-segments which act as voltage-sensors in 
voltage-gated ion channels. In order to elucidate the mechanism by which GPCRs detect 
alterations in the membrane potential, mutagenesis studies mainly at the M2AChR have 
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been carried out in search of a GPCR voltage-sensor. Neither mutation of amino acids in 
the binding pocket nor of a conserved sequence motif identified the voltage-sensor but 
only led to allosteric modulation of voltage-dependence. As yet, the search for the voltage-
sensor has not been successful. Therefore, we engaged in the search of amino acids 
involved in the detection of membrane potential alterations with mutants of the FRET-
based intramolecular fusion protein of α2A-AR.  
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4  Materials 
4.1 Technical equipment 
4.1.1 General technical equipment 
Accu-jet pro BRAND GMBH + CO KG, 
Wertheim  
Digital Sonifier Branson Ultrasonics Corp., Danbury, 
USA 
Feinwaage 770 (precision balance) KERN & Sohn, Balingen-Frommern  
FiveEasy pH meter Mettler Toledo, Gießen  
FLUOstar OPTIMA BMG Labtech, Ortenberg 
Freezer (-80°C) FORMA 900 Series Thermo Scientific, Waltham, USA  
Freezer Premium NoFrost Liebherr, Biberach a. d. Riss  
Fridge Profiline Liebherr, Biberach a. d. Riss 
Heat sterilization Heraeus Oven Thermo Scientific, Waltham, USA 
Heraeus Fresco 17 Centrifuge Thermo Scientific, Waltham, USA 
Heraeus Megafuge 16R Centrifuge Thermo Scientific, Waltham, USA 
Horizontal shaker 3015 GFL, Burgwedel  
Ice flaker F100 Compact Icematic, Düsseldorf 
Incubator APT.lineTM C150 Binder, Tuttlingen  
Magnetic stirrer MR Hei-Standard Heidolph Instruments, Schwabach  
Microwave R-202 SHARP Electronics, Hamburg  
Nano photometer Implen, München 
Pipette Gilson Pipetman Gilson, Limburg-Offheim 
Steam sterilization VX-95 Systec GmbH, Linden  
Sterile workflow LabGard ES NU-437 Class II, 
Type A2 Biosafety Cabinet 
NuAire, Plymouth, USA 
Sterile workflow SK 1200 BDK, Sonnenbühl-Genkingen 
Thermocycler SensoQuest, Göttingen  
Thermomixer comfort Eppendorf, Hamburg  
Ultra Clear UV plus (ultra-filtered water device) SG, Hamburg  
Vortex – Genie 2 Scientific Industries, Bohemia, USA  
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4.1.2 Technical equipment for FRET measurements 
100x oil immersion objective A-Plan Zeiss, Oberkochen  
Air-cushioned optical table  Newport Corp., Stahnsdorf 
Attofluor Invitrogen, Darmstadt 
Dichroic beam splitter DCLP 460 Chroma Technology, Bellows Falls, 
USA 
Dichroic beam splitter DCLP 515 Chroma Technology, Bellows Falls, 
USA 
Dual-emission photometry system TILL Photonics, Gräfelfing 
Emission filter CFP D480/40M Chroma Technology, Bellows Falls, 
USA 
Emission filter YFP HQ535/30M Chroma Technology, Bellows Falls, 
USA 
EPC-10 amplifier HEKA Elektronik Dr. Schulze 
GmbH, Lambrecht 
Excitation filter ET 436/20x Chroma Technology, Bellows Falls, 
USA 
Inverted microscope Axiovert 135 Zeiss, Oberkochen  
Micromanipulator MMJ Märzhäuser, Wetzlar 
Perfusion system ALA VC3-8SP  ALA Scientific Instruments, 
Farmingdale, USA  
Polychrome V light source TILL Photonics, Gräfelfing 
4.1.3 Technical equipment for electrophysiological measurements 
2.0 mm square box filament, 2.0 mm wide Science Products GmbH, Hofheim 
am Taunus 
Air-cushioned optical table  Newport Corporation, Stahnsdorf 
EPC-10 amplifier HEKA Elektronik Dr. Schulze 
GmbH, Lambrecht 
Micromanipulator MHW Narishige, London, UK 
Puller P-87 Sutter Instruments, Navato, USA 
4.1.4 Other technical equipment  
1600TR scintillation counter Packard Instruments, Downers 
Grove, USA 
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Axoclamp 2B amplifier Axon Instruments, Union City, USA 
DMI 6000B epifluorescence microscope 
DFC360 FX camera 
Leica, Wetzlar 
LS-2800 scintillation counter Beckman Coulter, Krefeld 
4.2 Consumables 
Borosilicate glass capillaries GC 150 F-10 Harvard Apparatus, Holliston, USA 
Cell culture dishes 6 cm, 10 cm (coated) Greiner, Solingen 
Cell culture plate 6-well (coated) Sarstedt, Nümbrecht 
Cover slips (diameter 24 or 25mm) VWR, Darmstadt 
GF/C glass fiber filters Whatman, Dassel 
MicroFil World Precision Instruments, 
Sarasota, USA 
Parafilm Brand, Wertheim 
Pasteur pipets Hartenstein, Würzburg 
PCR-Tubes 0,2 mL Brand, Wertheim 
Petri dishes (uncoated) Hartenstein, Würzburg 
Pipet tips 10 µL, 200 µL, 1000 µL Greiner, Solingen 
Reaction tubes 1,5mL Hartenstein, Würzburg 
Reaction tubes 15 mL und 50 mL Greiner, Solingen 
4.3 Chemicals 
[3H]-clonidine hydrochloride Perkin Elmer, Waltham, USA 
[3H]-noradrenaline hydrochloride Perkin Elmer, Waltham, USA 
Adrenaline hydrochloride Sigma-Aldrich, Steinheim  
Agar AppliChem, Darmstadt  
Ampicillin AppliChem, Darmstadt 
Calcium chloride Sigma-Aldrich, Steinheim 
cOmplete ULTRA Tablets, Mini, EDTA-free 
EASY pack (protease inhibitor cocktail)  
Roche, Mannheim 
Desoxyribonucleotides (dNTPs) New England Biolabs, Frankfurt 
Dimethyl sulfoxide Sigma-Aldrich, Steinheim 
DMEM high glucose (4,5 g/L) Capricorn, Ebsdorfergrund  
Dobutamine hydrochloride Alfa Aesar, Lancashire, UK 
Dopamine hydrochloride Sigma-Aldrich, Steinheim  
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EDTA Sigma-Aldrich, Steinheim 
Effectene Transfection Reagent Qiagen, Hilden  
EGTA Sigma-Aldrich, Steinheim  
Ethanol absolute Roth, Karlsruhe 
Ethidium bromide Promega, Mannheim 
FCS superior  Biochrom, Berlin 
G418 Sulphate PAA, Pasching 
HEPES Sigma-Aldrich, Steinheim 
Immersol 518F Immersion oil Zeiss, Oberkochen  
Isopropanol Roth, Karlsuhe 
Isoproterenol Sigma-Aldrich, Steinheim 
Kanamycin sulfate Roth, Karlsuhe 
LB-Medium-powder according to Lennox AppliChem, Darmstadt 
LE Agarose Biozym Scientific, Hessisch 
Oldendorf  
L-glutamine 200 mM Biochrom, Berlin 
Magnesium chloride Sigma-Aldrich, Steinheim  
Noradrenalin bitartrate  Sigma-Aldrich, Steinheim  
Opti-Fluor Scintillation liquid Packard Instruments, Downers 
Grove, USA 
Paraformaldehyde (PFA) Sigma-Aldrich, Steinheim  
PBS Biochrom, Berlin 
Penicillin/Streptomycin (10.000 U/mL; 10 mg/mL) Biochrom, Berlin 
Poly-L-lysine hydrobromide Sigma-Aldrich, Steinheim  
Potassium acetate Sigma-Aldrich, Steinheim  
potassium chloride Sigma-Aldrich, Steinheim  
sodium chloride Sigma-Aldrich, Steinheim  
Tris Sigma-Aldrich, Steinheim  
Trypsin/EDTA (1:250) Biochrom, Berlin 
VECTASHIELD Vector Laboratories Inc., 
Burlingame, USA 
Yohimbine hydrochloride Sigma-Aldrich, Steinheim  
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4.4 Enzymes 
Dpn1 New England Biolabs, Frankfurt 
Pfu DNA polymerase Promega, Mannheim 
Phusion high-fidelity DNA polymerase New England Biolabs, Frankfurt 
RNAse A Roth, Karlsruhe 
4.5 Plasmids 
Plasmid Species Origin 
CFP-Arr3 bovine Cornelius Krasel 
CFP-Gγ2 human (Hein et al., 2005) 
GRK2 human (Winstel et al., 1996) 
Gαs-wt rat (Hein et al., 2006) 
Gαs-YFP human (Hein et al., 2006) 
Gβ1-wt human (Bünemann et al., 2003) 
α2A-AR wt mouse (Bünemann et al., 2003) 
α2A-AR-cam mouse (Vilardaga et al., 2003) 
α2A-AR-YFP mouse (Hein et al., 2005) 
β1-AR wt human Bünemann lab 
β1-AR-sensor 
(Arg389) 
human Provided by Prof. Stefan Engelhardt  
(Rochais et al., 2007) 
β1-AR-YFP (Arg 389) human mutated to Arg389 during this thesis 
(Birk et al., 2015) 
β2-AR-sensor human kindly provided by Prof. Stefan Engelhardt  
(Ahles et al., 2011) 
β2-AR-YFP human Bünemann lab 
4.6 Primers for Quick Change® Mutagenesis  
Beta1 G389R for CAAGGCCTTCCAGAGACTGCTCTGCTGC 
Beta1 G389R rev GCAGCAGAGCAGTCTCTGGAAGGCCTTG 
α2A-L75K, D79A-cam  CCAAGGCCTCAGCGGCCATCCTGGTGGCCACG 
Other mutated receptor-sensor constructs discussed in this thesis have been constructed by 
Anna-Lena Krett. 
4.7 Kits 
Plasmid Midi Kit Qiagen, Hilden 
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QIAquick Gel Extraction Kit Qiagen, Hilden 
mMessage mMaschine transcription kit Ambion, Kaufungen 
Pierce BCA Protein Kit Thermo Scientific, Waltham, USA 
4.8 Software and Databases 
ApE -A plasmid Editor M. Wayne Davis 
BLAST http://blast.ncbi.nlm.nih.gov/Blast.cgi 
Corel Draw X5 Corel Corporation, Ottawa, Canada 
Fluorescence Spectra Viewer http://www.thermofisher.com/de/de/home/life-
science/cell-analysis/labeling-
chemistry/fluorescence-spectraviewer.html 
GPCRDB www.gpcr.org/7tm/ 
GraphPad Prism 5 GraphPad Software, La Jolla, USA 
IUPHAR www.guidetopharmacology.org 
Mendeley Desktop Mendeley, London, UK 
Microsoft Office Professional Plus 2010 Microsoft, Redmond, USA 
Optima BMG Labtech, Ortenberg 
OriginPro 8.5.0 SR1 OriginLab Corporation, Northampton, USA 
Patchmaster 2.5  HEKA Elektronik Dr. Schulze GmbH, Lambrecht 
Primer X www.bioinformatics.org/primerx 
Pubmed www.ncbi.nlm.nih.gov/pubmed 
4.9 E.coli strain and cell lines 
The chemically competent E.coli strain DH5α was used for plasmid amplification. 
Experiments were performed in HEK 293 or HEK 293T cells. 
4.10 Buffers and Media 
Standard buffers and media are listed here. Buffers which are specific to only one 
method are mentioned in the corresponding section. Ultra-filtered water was used in all 
buffers (H2O from here on). 
FRET-buffer, pH 7,3  LB medium 
137 mM NaCl  20 g LB medium powder according to Lennox  
5.4 mM KCl  in 1 L H2O 
10 mM HEPES  autoclaved 
1 mM MgCl2   
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Internal solution  Cell culture medium 
100 mM potassium 
aspartate 
 500 mL Dulbecco’s Modified Eagle’s Medium 
high glucose 
40 mM KCl   10% (v/v) fetal calf serum 
5 mM NaCl  2 mM L-glutamine 
7 mM MgCl2  100 U/mL penicillin 
20 mM HEPES  0.1 mg/mL streptomycin 
10 mM EGTA   
25µM GTP   
5 mM sodium ATP   
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5 Methods 
5.1 Cell culture 
5.1.1 Cultivation of human embryonic kidney 293 cells 
The human embryonic kidney (HEK) cell-lines HEK 293 and HEK 293T were used in 
this study. They were cultured in an incubator at 37°C, 90-95% humidity and 5.0% CO2. 
Cells were grown in DMEM (Dusbecco’s Modified Eagle’s Medium high glucose) 
supplemented with 10% (v/v) fetal calf serum (FCS), 2 mM L-glutamine, 100 U/mL 
penicillin and 0.1 mg/mL streptomycin. For stably transfected cell lines the additional 
selection antibiotic G418 (0.5mg/mL) was added to the culture medium. 
HEK 293T cells were passaged three times, stably transfected HEK 293 cells two times 
per week. Trypsin/EDTA (0.05/0.02% in Dulbecco’s PBS without Mg2+/Ca2+) incubation 
for one minute helped to detach the adherent cells from the culture plate. Trypsin activity 
was stopped by the addition of new medium which was also used to wash the detached 
cells from the dish. Centrifugation for 3 min at 1000 rpm (Heraeus Fresco 17 centrifuge) 
pelleted the cells which were then resuspended in medium and seeded onto new culture 
dishes at an appropriate density. 
5.1.2 Transient transfection of HEK 293T cells with Effectene 
To transfect cells, DNA is introduced into eukaryotic cells. Depending on whether the 
introduced DNA integrates into the cell’s genome or only resides in the cytosol as a 
circular plasmid, the transfection is stable or transient, respectively. Spontaneous 
integration into the genome, i.e. stable transfection, occurs only to a small percentage 
which is why most of the cells lose transfected plasmids during mitosis.  
At least 8 hours before transfection, HEK 293T cells were split onto 6 cm dishes in a 
density that resulted in about 50% confluency at the time of transfection. Transfection of 
HEK 293T cells was achieved with Effectene transfection reagent (Qiagen), a non-
liposomal lipid formulation, following Qiagen instructions. Experiments were conducted 
on the second day after transfection.  
5.1.3 Transfer of transfected cells onto poly-L-lysine coated glass cover slips 
For fluorescence microscopy experiments transfected cells were transferred onto glass 
coverslips (CS) the day before the experiment. To allow stable adherence of the transfected 
cells during the measurements in which they were constantly superfused, CS were coated 
with poly-L-lysine. Cover slips were sterilized with 70% ethanol and put upright into the 
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wells of 6-well-plates until the ethanol evaporated. After sterilization the CS were 
incubated with 100 µL poly-L-lysine for 30 min. The excessive poly-L-lysine was 
removed and the cover slips were washed with PBS. Transfected cells were split onto the 
CS in a low density that allowed single cell FRET measurements the following day. 
5.2 Molecular Biology 
5.2.1 Transformation of E. coli 
To amplify plasmid DNA in E.coli (DH5α strain), chemically competent E.coli were 
transformed. A mix of 100 µL competent E.coli, 20 µL 5x potassium-calcium-magnesium 
(KCM) buffer, 80 µL H2O and 0.2-2 µg plasmid DNA was incubated on ice for 
20 minutes. A 10 minutes incubation time at room temperature (RT) followed. 1 mL LB 
medium was added to the mixture and the bacteria were grown shaking at 37°C for 
50 minutes (Thermomixer comfort, Eppendorf). The bacterial culture was then plated on 
an antibiotic-containing agar plate (ampicillin or kanamycin) and cultured overnight at 
37°C. As the plasmids contain resistance genes against either of the two antibiotics, only 
bacteria that took up the plasmid DNA survived on the agar plate and formed colonies 
overnight.  
5x KCM-Puffer 
500 mM KCl 
150 mM CaCl2 
250 mM MgCl2 
5.2.2 Plasmid preparation from E. coli 
Medium-scale plasmid preparation (Midi preparation, 100 mL E.coli overnight cultures) 
was done using the Qiagen Plasmid Midi Kit following the manufacturer’s instructions. 
This kit is based on the alkaline lysis method (Birnboim and Doly, 1979). The DNA pellet 
was resuspended in H2O and stored at -20°C. 
Small-scale preparation (Mini preparation) was carried out using a protocol modified 
from Birnboim and Doly and self-made buffers but no purification columns. 1.5 mL out of 
5 mL overnight cultures were centrifuged for 2 min at 13,300rpm (Heraeus Fresco 17 
Centrifuge used for all centrifugations, Thermo scientific) and resuspended in 100 µL 
resuspension buffer. 2 µL RNAseA were added to ensure RNA digestion and to increase 
DNA purity. 200 µL lysis buffer were added to lyse the bacteria. A 3-5 min incubation 
time at RT ensured bacterial lysis. Addition of 150 µL neutralization buffer neutralized the 
pH and precipitated proteins and bacterial genomic DNA during a 5 min incubation on ice. 
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In the following centrifugation (10 min, 13,300 rpm) the precipitate was pelleted. The 
plasmid DNA containing supernatant was mixed with 450 µL isopropanol and incubated 
for 5 min to precipitate the plasmid DNA which was then pelleted by centrifugation 
(10 min, 12,000 rpm). The pellet was washed with 70% ethanol, air-dried and resuspended 
in H2O. DNA from Mini preparations was only used in control digestions as its purity was 
not sufficient for sequencing, cloning, transformation or transfection. In order to use Mini 
preparation DNA for one of these purposes it was purified using the Qiaquick Gel 
Extraction Kit (Qiagen) following the manufacturer’s protocol. 
Resuspension buffer Lysis buffer Neutralization buffer 
50 mM glucose 0.2 M NaOH 3 M potassium aspartate  
10 mM EDTA 1% (w/v) SDS 11% (v/v) acetic acid (96%) 
25 mM Tris(base) in H2O in H2O 
pH 8.0, in H2O   
5.2.3 Measurement of DNA concentration  
DNA concentrations were measured with a Nano photometer (Implen). Since all DNA 
solution were prepared with H2O, it served as a blank in the measurements. To determine 
the concentration of each sample, the absorbance at 280 nm and 320 nm was measured 
relative to the absorbance of the blank value. 
5.2.4 Quick Change® site-directed mutagenesis 
Site-specific mutations like base exchanges in double-stranded plasmids leading to 
amino acid exchange in the encoded protein can be achieved by PCR-based 
QuickChange® site-directed mutagenesis (Braman et al., 1996). Primers for this method 
carry a mismatch to the parental plasmid strand approximately in their center. Aside from 
this mismatch both primers are complimentary to one of the parental plasmid strands. 
Compared to a conventional PCR reaction, the whole double-stranded plasmid is amplified 
during the mutagenesis. For this reason the elongation phase is greatly prolonged and a 
polymerase with proof reading capacity is necessary to avoid additional, unwanted 
mutations. Reactions were performed with Phusion high-fidelity DNA-polymerase and the 
following components were included in the reaction tube: 
 
 
 
Methods 
29 
Phusion  
10 µL 5x GC buffer 
25-50 ng DNA template 
0,2 µL 5‘-mutagenesis primer (100 pmol/µL) 
(0,2 µL 3‘-mutagenesis primer (100 pmol/µL))* 
2 µL dNTP-mix 
0.5-1 µL Phusion polymerase  
(3.5 µL DMSO)* 
ad 50 µL H2O 
* Components in parentheses where only present in some of the mutagenesis reactions. 
 
The mutagenesis reaction was performed in a thermocycler (SensoQuest) in 16 or 35 
cycles. Before the first cycle and as a first step of each cycle, the mixture was heated to 
95°C or 98°C for 30 s (up to 4 min before first cycle) to denature the double-stranded 
plasmid. This strand separation allowed primer binding to the single strands during the 
annealing phase. The annealing temperature depended on the primer sequence, ranged 
between 56°C and 60°C and was set for 30 s. After primer annealing the temperature was 
increased to the optimum working temperature of the polymerases (72°C). During this 5-
11 min elongation phase the plasmid strands were replicated. After elongation the 
temperature increased to 95°C/98°C again and the next cycle started. After the last cycle 
the elongation temperature was set for another 10 min to allow elongation of unfinished 
strands.  
To separate new, mutated strands from template strands a digestion of the PCR mix 
with the endonuclease Dpn1 followed. Dpn1 specifically digests methylated DNA, i.e. the 
parental template DNA, but not the unmethylated strands produced during the PCR 
reaction. To increase digestion efficiency, an ethanol precipitation of the PCR-DNA 
preceded Dpn1-digestion. E.coli were transformed with 5 µL of the reaction mix. After 
DNA preparation the success of the mutagenesis was controlled by sequencing.  
5.2.5 Sequencing 
Mutated and cloned plasmid DNAs (100 µg/µL, in H2O) were sent for sequencing to 
Eurofins Genomics. Sequencing was carried out using standard primers CMVfw and/or 
pcDNA3rev as the constructs resided in a pcDNA3 backbone vector. To verify the G389R 
mutation in β1-AR-YFP, the standard sequencing primer EGFPN1rev was used.  
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5.3 Radio-ligand binding 
Radio-ligand binding assays were performed in intact Xenopus leavis oocytes 
expressing α2A-AR to investigate voltage-dependent agonist binding. In cell membranes of 
HEK 293 cells α2A-AR density was measured. 
5.3.1 Radio-ligand binding in oocytes 
5.3.1.1 Buffers for oocyte culture and binding experiments 
Oocytes were cultured in standard oocyte culture medium (NDE). The membrane 
potentials of about -88 mV and +5 mV were induced by solutions of low (ND) and high 
(HK) potassium concentration, respectively (Ben-Chaim et al., 2003, 2006).  
ND96 (ND) Enriched ND96 (NDE) ND 0 Ca2+ High K+ (HK) 
96 mM NaCl ND96 96 mM NaCl 2 mM NaCl 
2 mM KCl  +2.5 mM Na+-pyruvate 2 mM KCl  96 mM KCl  
1 mM MgCl2 +100U/mL penicillin 1 mM MgCl2 1 mM MgCl2 
1 mM CaCl2 +100 µg/mL streptomycin 5 mM HEPES 1 mM CaCl2 
5 mM HEPES   5 mM HEPES 
The pH of these solutions was adjusted to pH 7.4 with NaOH (ND96, NDE, ND 0 Ca2+) or 
KOH (HK). 
5.3.1.2 Preparation of cRNA and injection of cRNA into oocytes 
Injection of Xenopus laevis oocytes was performed with cRNA of the α2A-AR and the 
two GIRK channel subunits GIRK1 and GIRK2. Linear cDNA encoding for the α2A-AR or 
the two GIRK subunits was transcribed in the following mix using the mMessage 
mMachineTM transcription kit (Ambion) according to the included protocol: 
 
10 µL 2x NTP/CAP 
2 µL 10x reaction buffer 
1 µg linear template DNA 
2 µL T7 polymerase 
 
cRNAs of α2A-AR (5ng/oocyte) and the two GIRK subunits (200pg/oocyte each) were 
injected into the oocytes one day after oocyte preparation in Ca2+-free ND96 solution (ND 
0 Ca2+). Control oocytes to estimate unspecific binding were not injected with cRNA. 
Injected and untreated oocytes were cultured at 18°C in NDE solution which was changed 
daily.  
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5.3.1.3 Two-electrode voltage-clamp 
Three to five days after cRNA injection GIRK currents were measured using the two-
electrode voltage-clamp technique (Axoclam 2B amplifier, Axon Instruments) to check for 
α2A-AR expression. Recording electrodes (15-40 MΩ) were pulled in a vertical puller, 
injecting electrodes (0.9-2 MΩ) in a horizontal puller both from 1.5 mm glass capillaries 
(Hilgenberg, Malsfeld). Both electrodes were filled with 500 mM KCl. An oocyte was 
immobilized in a small chamber filled with ND96 solution and both pipettes were inserted 
for current measurements. ND96 was replaced by 48 mM K+ solution (HK:H2O 1:1) via a 
gravity perfusion system to measure GIRK currents. To check for α2A-AR expression, the 
oocyte was then superfused with 48 mM K+ solution containing 10 µM noradrenaline. 
Batches of oocytes showing an increase in GIRK currents upon stimulation with 
noradrenaline were used for radio-ligand binding experiments.  
5.3.1.4 Binding assay 
[3H]-NA binding (specific activity 48.4 Ci/mmol) to α2A-AR expressing oocytes was 
measured in intact oocytes at two membrane potential induced by solutions of different 
potassium concentration 3-5 days after cRNA injection. One oocyte at a time was 
incubated either in ND or HK solution containing a given concentration of [3H]-NA for 
30 s. Using a glass pipette inserted into a standard 200 µL pipette tip the oocyte was 
transferred from the radio ligand solution into a special washing device (Ben-Chaim et al., 
2003) filled with 4 mL ligand free ND or HK solution (the same solution as the [3H]-NA 
containing one). Within 2 seconds the oocyte sank to the ground of the conical washing 
chamber and was removed from it. The oocyte was placed into a vial which was then filled 
with 3 mL scintillation liquid (Opti-Fluor, Packard Instruments). Radioactivity was 
counted in a LS-2800 scintillation counter (Beckman). Oocytes which have not been 
injected with cRNA were measured in the same way alternating with injected ones to 
determine the amount of nonspecific binding of [3H]-NA.  
The average of nonspecific binding in each set of experiments was subtracted from the 
total binding of individual oocytes to calculate specific binding. Specific binding of the 
injected oocytes was then averaged and displayed as average±SEM. Only when specific 
binding could be detected in measurements in ND solution, binding experiments in HK 
solution were performed.  
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5.3.2 Measurement of α2A-AR density in membranes of HEK 293 cells 
To estimate α2A-AR density in transiently transfected HEK 293 cells, [3H]-clonidine 
hydrochloride ([3H]-Cl) (specific activity 57.8 Ci/mmol) binding to cell membranes 
prepared from these cells was measured.  
5.3.2.1 Membrane preparation 
Receptor expressing cells cultured in 10 cm culture dishes were washed once with PBS 
and detached from the dish with a cell scraper in 1 mL buffer (in mM: 150 NaCl, 20 
NaH2PO4 H2O, 3 MgCl2, 1 EDTA and 1 tablet protease inhibitor cocktail (Roche) per 
10 mL buffer, pH 7.4). Cells were pelleted by centrifugation for 1 hour at 13,300 rpm at 
4°C (Heraeus Fresco 17 Centrifuge). Pellets were resuspended in resuspension buffer (in 
mM: 100 NaCl, 20 Tris base, pH 7.4) and sonified. Protein concentration was determined 
using a PierceTM BCA Protein Assay kit (Thermo Scientific) following the manufacturer’s 
instructions. 
5.3.2.2 Radio-ligand binding  
Total [3H]-Cl binding was performed in triplicates. To determine unspecific binding to 
transfected cells 10 µM cold yohimbine hydrochloride (Yoh) was added to the [3H]-Cl 
binding mix and was measured in duplicates. 25 µL membrane preparation was incubated 
with either [3H]-Cl or [3H]-Cl+Yoh both in resuspension buffer shaking over night at 4°C. 
GF/C glass fiber filters (Whatman) were used to separate bound and unbound ligand by 
vacuum filtration. Filters were washed four times with ice-cold 50 mM Tris base (pH 7.4), 
transferred to vials containing 2 mL scintillation liquid and radioactivity was counted in a 
Packard1600TR beta counter. Counts per minute (cpm) measured by the beta counter were 
transformed into disintegrations per minute (dpm) using the following formula: 
dpm= (cpmsample-cpmbackground)/detector efficiency 
The detector efficiency for [3H] was 20%. The average unspecific binding detected in 
duplicates in the presence of cold Yoh was subtracted from the total binding value of each 
sample to calculate specific binding. Specific binding of triplicate values was then 
averaged and the amount of receptor in each membrane sample was calculated using the 
specific mol/dpm factor of [3H]-Cl (7.79*10-18 mol/dpm). BCA data were used to 
determine the amount of protein per 25 µL membrane preparation and the receptor density 
(pmol receptor/mg membrane protein) was calculated.  
Data of three transfections of α2A-AR together with Epac1-camps and AC5 were pooled. 
Untransfected cells were also measured in triplicates with [3H]-Cl or in duplicates with 
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[3H]-Cl+Yoh to confirm specific binding of [3H]-Cl to α2A-AR. No specific binding was 
detected in untransfected cells. The density of α2A-AR was 10.98±0.9 pmol/mg membrane 
protein.  
5.3.3 Förster resonance energy transfer measurements in single living cells 
Cells transiently or stably expressing the fluorescently labeled proteins under 
investigation were split onto poly-L-lysine coated cover slips the day before the 
measurements (5.1.3). FRET measurements were conducted in single living cells the 
following day.  
5.3.3.1 Theoretical background 
Based on theories of Jean Perrin, Theodor Förster described the transition of electron 
excitation energy between two similar molecules in solution (Förster, 1948), a process we 
today call Förster or fluorescence resonance energy transfer, short FRET.  
FRET can occur between two fluorophores when an excited donor fluorophore 
transmits its energy radiation-free onto an acceptor fluorophore. This acceptor can either 
transmit the energy to yet another acceptor or emit it as light. There are three main 
prerequisites for this transfer to happen (Lohse et al., 2012): 1) The transition dipole 
orientation should ideally be parallel. 2) The donor emission and acceptor excitation 
spectra need to overlap (Figure 5). The most frequently used FRET pair consists of the 
donor CFP and the acceptor YFP. The fluorophores are spectral variants of the green 
fluorescent protein (GFP) found in the jellyfish Aequorea Victoria (Prasher et al., 1992; 
Heim and Tsien, 1996). An excitation wavelength of 430 nm in the FRET measurements 
performed in this study mainly excited CFP (Figure 5). CFP could then transfer its energy 
to YFP if 3) the distance between the fluorophores relative to each other is within 1-100Å. 
This makes FRET an ideal tool to study protein-protein interaction (intermolecular FRET) 
or to monitor protein conformational changes (intramolecular FRET) in living cells.  
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Figure 5: Excitation and emission spectra of CFP and YFP.  
Excitation (dashed curves) and emission (solid lines) spectra of CFP (blue) and YFP (green) are shown. The 
overlap of CFP emission (solid blue) and YFP excitation (dashed green) is nicely visible. Purple, light blue 
and green rectangles correspond to the bandwidths of the excitation, CFP emission and YFP emission filters, 
respectively. The image was modified from an image produced with the Thermo Fisher Scientific 
Fluorescence Spectra Viewer. 
There are several ways to measure FRET. In this study the FRET approach of sensitized 
emission (simply called FRET in this thesis) was used in which the acceptor emits light 
after excitation by a donor via FRET (Lohse et al., 2012). Measurements of sensitized 
emission usually include correction of the total YFP emission by two factors: “direct 
excitation” of the acceptor by the donor excitation wavelength and “bleed through” of the 
donor emission into the acceptor emission channel both due to spectral overlap (Berney 
and Danuser, 2003). In this thesis corrections of the YFP emission could not be carried out. 
Combination of FRET measurements with electrophysiology did not allow measurement of 
total YFP emission after each measurement which would be needed to calculate the actual 
YFP emission after subtraction of bleed-through and direct excitation.  
5.3.3.2 Preparation of agonist solutions 
Stock solutions of a concentration of 10 mM were prepared for all agonists by weighing 
in a defined amount of each substance and dissolving it in the appropriate amount of FRET 
buffer. Dissolving of dobutamine (DOB) was achieved by gentle shaking and warming to 
40°C (Thermomixer comfort). Ascorbic acid was added to each solution to prevent 
oxidation. Stock solutions of isoprenaline (Iso), noradrenaline (NA) and DOB were stored 
at -20°C and used repeatedly whereas solutions of adrenaline (Adr) and dopamine (DA) 
were prepared freshly on each measuring day. Stock solutions were then used to prepare 
10 mL of the desired agonist concentration in FRET buffer (4.10) for FRET measurements. 
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5.3.3.3 Förster resonance energy transfer measurements (sensitized emission) 
On the measuring day cover slips were mounted in an Attofluor cell chamber 
(Invitrogen), washed twice with FRET buffer and covered with FRET buffer. 
Measurements were conducted at room temperature on an inverted Axiovert 135 (Zeiss) 
microscope equipped with a 100x-A-Plan oil immersion objective (Zeiss) and a dual-
emission photometric system (TILL Photonics). Transfected cells expressing both 
fluorophore-labeled proteins at their appropriate location within the cell were selected in a 
dual excitation mode. In the FRET measurement mode cells were excited with a 
wavelength of 430 nm (excitation filter ET 436/20x, DCLP 460 nm, Chroma Technology), 
a frequency of 2.5 Hz or 5 Hz and an illumination time of 5 ms with a polychrome V light 
source (TILL Photonics). Emission intensities of both fluorophores (F535, F480; DLCP 515, 
emission filter CFP D480/40M and YFP HQ535/30M, all Chroma Technology) were 
detected separately by high-resolution photodiodes (TILL Photonics). An analogue-digital 
converter included in the EPC-10 amplifier (HEKA) converted fluorescence intensity 
signals into digital data which were stored on a computer using Patchmaster software 2.42 
(HEKA). To investigate agonist-mediated changes in FRET, cells were continuously 
superfused with buffer or buffer containing agonist by a pressurized perfusion system 
VC3-8SP (ALA Scientific Instruments) which enabled solution exchange in less than 
10 ms. A black bar in each graph labeled with the concentration and type of agonist 
indicated the duration of agonist application. 
5.3.3.4 F535, F480, F535/F480  
As the emission intensity was not corrected in the FRET measurements, single channel 
fluorescence intensities are labeled according to the specifications of the emission filters 
(D480/40M and HQ535/30M) in the setup: F480 and F535 correspond to the channels, in 
which mostly donor and acceptor emissions were measured, respectively (Figure 5). The 
acceptor-over-donor emission ratio was calculated (F535/F480) and is simply referred to as 
‘ratio’ in this thesis.  
5.4 Control of the membrane potential by patch-clamp electrophysiology 
Ionic currents across the plasma membrane or the plasma membrane potential can be 
measured by means of patch-clamp electrophysiology in the voltage-clamp or current-
clamp mode, respectively (Hamill et al., 1981). In this study the membrane potential of 
cells expressing fluorescently labeled proteins suited for FRET (5.3.3.1) was set to desired 
values using patch-clamp in the voltage-clamp mode. A patch pipette filled with internal 
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solution (similar ionic composition as cytosol, 4.10) was positioned close to the cell 
membrane with a micromanipulator under optical control. By the application of slight 
suction a tight seal between patch pipette and the plasma membrane (giga seal) was 
achieved. Further suction opened the plasma membrane patch within the pipette without 
breaking the seal (whole-cell configuration). By means of a patch amplifier (EPC-10, 
HEKA) set to voltage-clamp mode the membrane potential (VM) was controlled. 
5.5 FRET measurements under direct control of the membrane potential 
A combination of FRET measurements and the patch-clamp technique in a voltage-
clamp mode was used to investigate conformational changes in a receptor molecule as well 
as alterations in protein-protein interaction due to variations in the plasma membrane 
potential. Figure 6 illustrates a cell transfected with an intramolecular receptor fusion 
protein in the whole-cell configuration. On each day of experiments borosilicate glass 
capillaries (GC150F-10, Harvard Apparatus) were pulled into patch pipettes (resistance of 
4-8 MΩ) using a horizontal P-87 pipette puller (Sutter Instruments). Starting from a 
holding potential of -90 mV the membrane potential was switched to one or various test 
potentials by means of the EPC-10 patch amplifier (HEKA). The course of the membrane 
potential during measurements is indicated as a black rectangular pulse bar below each 
measurement. Simultaneously, cells were excited and the fluorescence intensities were 
recorded (5.3.3.3).  
 
 
5.6 Data evaluation and statistics 
Emission intensities at 480±20 nm (D480/40M) and at 535±15 nm (HQ535/30M) were 
recorded with Patchmaster software 2.42 which also calculated the ratio of F535/F480. Raw 
data were exported as AscII files and evaluated using OriginPro 8.5.0 SR1 (OriginLab 
Corp.) or GraphPad Prism 5 (GraphPad Software Inc.). All data in the study are presented 
either as individual experiments or averaged data ±standard error of the mean (SEM). The 
number of measurements per condition is stated as n=x in the figure legends.  
Figure 6: Schematic of combined FRET and 
electrophysiology measurements. 
A cell expressing an intramolecular receptor fusion 
protein is excited with a wavelength of 430 nm (dark 
blue) and donor (F480, light blue) and acceptor (F535, 
yellow) emissions were recorded. Simultaneously, cells 
were superfused with buffer or agonist-containing 
buffer with a pressurized perfusion system (left) and the 
membrane potential was controlled in whole-cell 
voltage-clamp configuration (patch pipette and 
amplifier, right). 
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5.6.1 Correction for photo bleaching 
Fluorophores are harmed by high intensity light pulses which leads to a decrease in 
fluorescence over time. This photo bleaching occurred in all FRET measurements but to a 
different degree depending on the excitation frequency and needed to be corrected for. 
Pronounced photo bleaching was present in 5Hz measurements of the FRET-based 
intramolecular fusion proteins β1-AR-sensor, β2-AR-sensor and α2A-AR-cam as well as 
their mutant forms. Correction for bleaching was achieved by subtraction of a mono-
exponential curve (dashed line) from the original acceptor-over-donor emission ratio as 
shown in a representative measurement of the β1-AR-sensor stimulated with 10 µM Adr 
(Figure 7, upper layer). The corrected ratio trace was then normalized to the starting value 
prior to agonist stimulation (Figure 7, lower layer) or to the maximal agonist-induced 
FRET amplitude (e.g. Figure 8C, D). Photo bleaching also occurred during 5 Hz 
measurements of receptor-G protein interaction and G protein activation and was corrected 
in the same manner as shown in Figure 7. 
 
 
 
5.6.2 Normalization 
In order to average data of different cells despite differences in initial acceptor-over-
donor emission ratio values, ratios of individual measurements were normalized. In FRET 
assays with high initial FRET (measurements of receptor activation or G protein 
activation) the bleach corrected ratios were normalized by dividing F535/F480 by the average 
FRET value before agonist stimulation (F535/F480 (norm.)). In FRET assays which show an 
increase of FRET upon agonist stimulation (receptor-G protein FRET, receptor-arrestin 
FRET), the (bleach corrected) ratio was calculated as ∆(F535/F480): The average FRET 
value before stimulation was subtracted from the ratio values at every given point. To 
compare deactivation kinetics, ratios were normalized to their maximal response. For this 
normalization ∆(F535/F480) at every given time was divided by the maximum agonist-
Figure 7: Correction for photo bleaching.  
In a representative measurement, a cell transiently 
transfected with the FRET-based β1-AR 
intramolecular fusion protein was stimulated with 
10 µM Adr. The ratio (F535/F480) is shown before 
(above) and after (below) correction for photo 
bleaching by subtraction of a mono-exponential 
curve (dashed line, τ=574 s). The bleach corrected 
ratio was normalized to the initial FRET value 
before stimulation. A black bar with agonist 
labeling above the ratio trace indicates the duration 
of Adr application. The time scale appears as a 
black bar. The bar below the trace shows the course 
of membrane potential (holding potential: -90 mV; 
test potential: +60 mV). 
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induced FRET response (∆(F535/F480)/∆(F535/F480)max) and is indicated as F535/F480 (norm to 
max.).  
5.6.3 Deactivation kinetics  
To perform evaluations of deactivation kinetics, the following mono-exponential 
function was fit to the appropriate section of individual experiments or the averaged data of 
‘n’ experiments using GraphPad Prism or Origin: 
Y=A*e(-k/x)+Y0, 
where Y0 is the Y value at x=0 s, A is the size of the signal and k the rate constant in s-1. 
The sections reached from the time-point of agonist withdrawal or start of depolarization to 
the plateau after washout or during depolarization. Koff values and standard errors were 
directly determined by GraphPad Prism with the equation mentioned here. 
5.6.4 Concentration-response curves 
Data for concentration-response curves were collected in a similar way to normal FRET 
measurements or FRET measurements in combination with patch-clamp. For a 
concentration-response curve of DA at the β1-AR, cells were stimulated with increasing 
concentrations of DA without washout between the different concentrations. FRET 
responses induced by different concentrations were normalized to the maximal FRET 
response by the highest agonist concentration. A concentration-response curve for Iso-
induced β1-AR-arrestin 3 interaction at two different potentials (-90 mV and +45 mV) was 
obtained in clamped cells stimulated with one test concentration and a reference 
concentration after washout of the first concentration. The test concentrations varied 
between cells whereas the reference concentration was the same. A switch between the 
holding potential and depolarization was performed in order to measure the Iso-induced 
FRET response during both potentials. Amplitudes at both potentials during stimulation 
with the test concentration were normalized to the amplitude of the reference concentration 
at rest (A+45/Arest or A-90/Arest).  
A concentration-response curve was fit using the following function in GraphPad Prism 
(“dose-response, variable slope”): 
Y=Bottom+(Top-Bottom)/(1+10((logEC50-x)*Hill Slope)), 
in which bottom/top are the values of the bottom/top plateau, x is the logarithm of the 
concentration, Y is the relative response amplitude, logEC50 is the x value when the 
response is 50% and the Hill Slope marks the steepness of the curve. The equation allowed 
for a variable slope.  
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5.6.5 Statistical tests 
To test for statistical significant differences between conditions the following statistical 
tests were performed in GraphPad Prism or Origin: One way ANOVA with Bonferroni ́s 
multiple comparison test to compare more than two conditions with each other; paired or 
unpaired Student’s t-test to compare two different conditions of paired or unpaired 
observations, respectively; extra sum of squares F-test for fit comparison.  
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6 Results 
6.1 The β1-adrenoceptor activity is voltage-sensitive 
In recent years voltage-sensitivity of a number of class A and C GPCRs coupling to Gi- 
or Gq-proteins has been reported (reviewed in (Mahaut-Smith et al., 2008)). But whether 
this regulation of receptor activation by the membrane potential also occurs in GPCRs 
coupling to the stimulatory Gs-protein has not yet been investigated. The β1-AR was used 
as a model Gs-coupled receptor to measure receptor activity as a function of the membrane 
potential. Ratiometric FRET measurements combined with patch-clamp electrophysiology 
were performed in HEK 293 cells which either stably or transiently expressed an 
intramolecular FRET-based fusion protein of β1-AR (β1-AR sensor (Rochais et al., 2007)). 
The crystal structure of the active state of the closely related β2-AR showed a rotation and 
large outward movement of TM6 compared to the inactive state (Rasmussen et al., 2007, 
2011b). With the intramolecular β1-AR sensor this activating conformational change can 
be monitored: The outward movement of TM6 upon agonist application leads to an 
increase in distance between the donor (Cer) and acceptor (YFP) fluorophores fused to the 
c-terminus and inserted into the third intracellular loop, respectively (Figure 8A). Thus, 
donor emission (blue) increased while acceptor emission (yellow) decreased during 
stimulation of the β1-AR sensor with 10 µM adrenaline (Adr) resulting in a decrease in 
acceptor-over-donor emission ratio (black trace, from here on only referred to as ratio or 
F535/F480) (Figure 8B, D) which reflects receptor activation (Rochais et al., 2007). Also 
stimulation with isoprenaline, another full agonist at the receptor (Bond et al., 2015), 
decreased the ratio, i.e. activated the receptor. This decrease was reversible upon washout 
of both ligands, indicating deactivation of the receptor (Figure 8B, C, D). Different 
concentrations of Iso and Adr were used to account for differences in affinities towards the 
β1-AR (Bond et al., 2015). When the membrane potential was depolarized from a holding 
potential of -90 mV to +60 mV during agonist application, the ratio increased very rapidly. 
This depolarization-induced change in ratio was reversible upon repolarization of the 
membrane to the former holding potential of -90 mV (Figure 8B, C, D).  
To verify that the changes in energy transfer induced by this large depolarizing step 
arose from a conformational change of the receptor molecule and not due to unspecific 
alteration of fluorophore emission, cells expressing the β1-AR sensor were subjected to 
depolarization in the absence of agonists (Figure 8E). 
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Figure 8: Membrane potential modulates agonist-induced β1-AR-sensor activity. 
In all figures, a black bar above measurements indicates the length and type of agonist application. The time 
scale is given as a black bar with a time in seconds in each graph. In cells subjected to voltage-clamp the 
applied change in membrane potential is indicated as a square pulse below the traces. In figures showing 
single fluorophore emission traces, the blue and yellow traces corresponds to donor (F480) and acceptor (F535) 
emission intensities, respectively. Blue and yellow ovals represent CFP and YFP fluorophores, respectively, 
a red diamond indicates the presence of an agonist. A small schematic of the FRET assay used is given in the 
first subfigure in which it was measured.  
A: An intramolecular FRET-based fusion protein of the β1-AR displays high initial FRET in unstimulated 
conditions. Stimulation with an agonist (red diamond) induces a decrease in FRET. Cells transiently (B, D) or 
stably (C, E) expressed the β1-AR-sensor. B: A representative measurement of a transiently transfected cell 
shows the course of YFP (yellow) and CFP (blue) emission and the acceptor-over-donor emission ratio (from 
here on termed “ratio”, black) stimulated with 10 µM Adr. The cell was subjected to whole-cell voltage-
clamp and the membrane potential was switched from the holding potential (-90 mV) to depolarization 
(+45 mV) during agonist application. C, D, E: Measurments were corrected for photo bleaching, normalized 
and smoothed using 5-point Savitzky-Golay-smoothing before calculation of the average±SEM. C and D: 
Cells were stimulated with 1 µM Iso (A) or 10 µM Adr (B), clamped to a holding potential of -90 mV and 
subjected to a depolarizing pulse to +60 mV during agonist application. Individual traces were normalized to 
the maximal agonist-induced change in FRET signal before averaging (average±SEM, A: n=9; B: n=8). 
Dashed lines indicate how amplitudes were measured for Figure 9. E: Cells were subjected to a depolarizing 
pulse to +60 mV in the absence of agonist. Individual measurements were normalized to the value prior to 
depolarization, then averaged (average±SEM, n=7). Alterations in the ratio induced by depolarization did not 
reach statistical significance (p=0.22).  
Results 
42 
In unstimulated cells depolarization did not alter the ratio, i.e. did not cause a 
conformational change in the receptor molecule and did not unspecifically alter 
fluorophore emission (Figure 8E). As the FRET signal of unstimulated β1-AR-sensors was 
unaltered during depolarization, the reduction in FRET amplitude (i.e. the agonist-evoked 
FRET signal) by depolarization in stimulated cells could be interpreted as voltage-induced 
receptor deactivation. 
These initial data showed that the voltage-sensitivity is an intrinsic property of β1-AR. 
Its activity is modulated by the membrane potential in such a way that depolarization 
deactivates the receptor. It can also be appreciated from these averaged measurements that 
deactivation by depolarization seemed to occur with much faster kinetics than deactivation 
by agonist withdrawal. This phenomenon points towards a change in agonist efficacy 
playing a role in voltage-sensitivity of β1-ARs and will be described in detail in section 
6.1.4.  
 
Figure 9: Saturation of β1-AR with agonist does not abolish depolarization-mediated receptor 
deactivation.  
A and B: The effect of depolarization on the β1-AR-sensor activity induced by stimulation with different sub- 
or saturating concentrations of Iso (A, n=8-11) or Adr (B, n=5-8) was quantified for measurements similar to 
those in Figure 8C and 4D. The dashed lines in Figure 8A and 1B indicate the baselines for the calculation of 
FRET amplitudes in the individual measurements. The quotient of FRET amplitudes during depolarization 
and during the holding potential was calculated in % and subtracted from 100% to obtain the percentage of 
depolarization-induced receptor deactivation. One way ANOVA with Bonferroni’s multiple comparison test 
was used to test for statistical significance. **: p<0.01; ***: p<0.001. 
Voltage-sensitivity of several GPCRs has been shown to act through alterations in 
agonist affinity (Ben-Chaim et al., 2003, 2006; Ohana et al., 2006; Rinne et al., 2013). One 
would assume that if only a reduction in agonist affinity underlay voltage-sensitivity of β1-
AR as well, stimulation with saturating concentrations of agonist would abolish 
depolarization-mediated deactivation similarly as described for the α2A-AR (Rinne et al., 
2013). This was not the case for Iso- or Adr-stimulated β1-AR in cells subjected to 
depolarization (Figure 9). To quantify the degree of voltage-induced deactivation, cells 
were stimulated with sub- or saturating concentrations of either Iso or Adr in 
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measurements similar to those in Figure 8C and D. Agonist-induced alterations in FRET 
(from here on FRET amplitudes) were measured before and during the depolarizing step to 
+60 mV in the individual measurements normalized to their maximal agonist-induced 
FRET amplitude (see dashed lines in Figure 8C, D). The relation of the latter over the 
former amplitude was calculated, subtracted from 1, calculated as percent deactivation and 
averaged over the given number of individual measurements (Figure 9). There was no 
significant difference in deactivation by depolarization when cells were activated by 
concentrations of Iso ranging from 100 nM to 100 µM (Figure 9A). Although increasing 
concentrations of Adr significantly reduced the depolarization-mediated deactivation, 
about 20% deactivation remained even when cells were stimulated with 500 µM Adr 
(Figure 9B). Depolarization induced stronger deactivation in cells stimulated with non-
saturating concentrations of Adr compared to non-saturating concentrations of Iso 
(compare about 55% deactivation to about 35% deactivation during depolarization and 
application of 1 µM Adr and 100 nM Iso, respectively). The remaining fraction of about 
20% deactivation by depolarization during receptor saturation, however, was comparable 
in Iso- and Adr-stimulated cells (Figure 9A, B).  
These data indicate that a reduction in agonist affinity which seemed more pronounced in 
Adr- than in Iso-stimulated cells contributes to the effect of voltage-dependence. However, 
the remaining effect of depolarization on receptor activity even in saturation points towards 
a contribution of altered agonist efficacy to β1-AR voltage-dependence, which is similar 
for Iso and Adr. 
6.1.1 G protein signaling is attenuated by depolarization 
With the β1-AR sensor we were able to monitor depolarization-dependent conformational 
changes of the agonist-stimulated receptor which reflected receptor deactivation. Apart 
from voltage-dependent changes in agonist binding other voltage-dependent GPCRs also 
showed altered downstream signaling upon depolarization (for example (Martinez-Pinna et 
al., 2005; Ohana et al., 2006; Sahlholm et al., 2011; Rinne et al., 2013, 2015)). But would 
depolarizing steps also influence downstream signaling of β1-AR? To answer this question 
we used FRET assays which monitored the G protein axis of β1-AR signaling. To analyze 
voltage-dependence of Gs protein activation, FRET was measured between the YFP-
labeled Gαs and CFP-Gγ2 subunits under co-transfection of non-fluorescent β1-AR and Gβ1 
subunit (Hein et al., 2006). In its inactive state the fluorescently labeled heterotrimeric 
G protein exhibits high initial FRET. Upon receptor activation the G protein interacts with 
active receptors and undergoes an activating conformational change which reduces the 
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affinity of the subunits to one another and to the receptor. A decrease in the energy transfer 
between CFP-Gγ2 and Gαs-YFP, i.e. a decrease in FRET, represents G protein activation 
(Figure 10A). Activation of the Gs protein by 30 nM Adr strongly activated the Gs protein. 
Opposing courses of donor and acceptor emissions calculated into a decrease in acceptor-
over-donor ratio during agonist stimulation (Figure 10B). Depolarization to +60 mV 
reversibly reduced the agonist-evoked FRET response. Stimulation with 0.3 nM Iso led to 
a ratio decrease in a single experiment which slowly recovered after withdrawal of the 
agonist (Figure 10C). Depolarization of the membrane to +60 mV deactivated the 
G protein almost completely despite continuous activation of β1-AR. After repolarization 
of the membrane the inhibition of G protein activation was abolished (Figure 10C).  
 
Figure 10: Signal transmission through G proteins is weakened during depolarization. 
Gs protein activation has been measured in cells transfected with YFP-labeled Gαs, CFP-Gγ and non-
fluorescent β1-AR and Gβ1. A: High initial FRET occurs in the absence of agonists. Upon stimulation the 
G protein interacts with the receptor. This enables G protein activation by a conformational change in the 
G protein which is indicated by a reduction in FRET. B: One of three successful experiments is shown in 
which cells were stimulated with 30 nM Adr. Individual traces of CFP and YFP emission run in opposing 
directions upon agonist stimulation and during depolarization to +60 mV indicating specific FRET. C: A 
single experiment of a cell stimulated with 0.3 nM Iso and depolarized to +60 mV during stimulation is 
shown. 
Due to differences in expression levels of the constructs among cells variations occurred 
in response to agonist stimulation. Many cells did not show agonist-evoked responses 
whereas in others G protein activation was saturated. Amplification of the signal at the 
level of G proteins and fast saturation of the system proved the measurements of voltage-
dependent Gs protein activation to be difficult. Therefore, only a few of many experimental 
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attempts succeeded and the results obtained have to be considered preliminary. It appears, 
however, as if G protein activation was also hampered during depolarization. More (high 
quality) experiments with low agonist concentrations will be necessary before a conclusive 
interpretation of the data is possible. 
 
 
Figure 11: Depolarization rapidly diminishes receptor-G protein interaction. 
A: The interaction between β1-AR and the Gs protein was monitored with a FRET assay between YFP-
labeled β1-AR (β1-AR-YFP) and the CFP-labeled Gγ2-subunit (CFP-Gγ) in the presence of unlabeled 
G protein subunits Gαs and Gβ1. Before stimulation, the receptor-G protein interaction assay displays low 
FRET. Stimulation of the receptor leads to the interaction of receptors and G proteins which results in an 
increase in FRET. B: Stimulation with 10 µM Adr enhanced energy transfer from CFP to YFP indicated by 
an increase YFP and a decrease in CFP emission intensity. Only minor alterations however to opposing 
directions are visible in the single emission traces. Those calculate into an increase in the ratio of acceptor-
over-donor emission intensity. Depolarization to +60 mV was performed during Adr-stimulation. C and D: 
Cells stimulated with 1 µM Iso (A: n=7) or 10 µM Adr (B: n=7) were depolarized to +60 mV during 
stimulation. Individual measurements were corrected for bleaching before the averages were calculated 
(average±SEM).  
As a reduction in agonist efficacy seemed to contribute to receptor deactivation during 
depolarization we aimed to investigate this effect also downstream of the receptor. Due to 
the signal amplification at the level of G proteins, the FRET assay monitoring G protein 
activation was not suitable for the investigation of alterations in agonist efficacy (Lohse et 
al., 2003). Therefore, we measured the interaction of β1-AR and the heterotrimeric 
Gs protein by means of FRET. Cells were transfected with YFP-labeled β1-AR (β1-AR-
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YFP), CFP-labeled Gγ2 subunit (CFP-Gγ) and unlabeled Gαs and Gβ1 subunits (Hein et al., 
2006). Stimulation with agonist triggers the interaction of receptor and the heterotrimeric 
G protein which can be detected by an increase in FRET (Figure 11A). YFP emission 
increased upon stimulation with 10 µM Adr while CFP emission slightly decreased 
resulting in an increase in acceptor-over-donor emission ratio (Figure 11B). Depolarization 
rapidly and reversibly diminished the interaction between β1-AR and G protein induced by 
Adr (Figure 11B). The average data of cells stimulated with 1 µM Iso (Figure 11C) or 
10 µM Adr (Figure 11D) also showed the interaction of receptor and G protein indicated 
by an increase in FRET. Withdrawal of the agonists terminated the interaction and the ratio 
decreased to baseline levels. During both Iso- and Adr-stimulation a depolarizing step to 
+60 mV quickly reduced the ratio, i.e. attenuated the interaction between receptor and 
G protein, which was reversible upon repolarization to the holding potential of -90 mV. 
Adr-stimulated cells were slightly more sensitive to the positive membrane potential than 
Iso-stimulated cells. The average reduction of receptor-G protein interaction by 
depolarization was 33.8±5% (Adr) and 28.2±5% (Iso). As seen for the β1-AR sensor 
deactivation, also the depolarization-induced weakening of receptor-G protein interaction 
occurred with faster kinetics than the disruption of interaction by washout of the ligands 
indicating a reduction in agonist efficacy (6.1.4). 
6.1.2 Depolarization weakens β1-adrenoceptor-arrestin 3 interaction  
In addition to G proteins, arrestins play an important role in GPCR signaling and 
desensitization. Therefore, it was interesting to find out whether depolarization also 
influenced the interaction of arrestin 3 with β1-AR. A FRET-based assay with β1-AR-YFP, 
N-terminally CFP-labeled arrestin 3 (CFP-Arr3) and unlabeled GPCR kinase 2 (GRK2) 
was used (Ahles et al., 2015) which will be referred to as the arrestin FRET assay. GRKs 
phosphorylate receptors in a ligand-dependent manner (Krasel et al., 2005) which is 
necessary for the recruitment of and interaction with arrestins (Lohse, 1993). A ratio 
increase reflects the interaction of β1-AR and arrestin 3 upon ligand activation and GRK 
phosphorylation (Figure 12A). Single emission intensity traces of a cell stimulated with 
100 nM Iso nicely show opposing courses upon agonist application: CFP intensity 
decreased as it transferred its energy onto YFP resulting in an increased YFP emission 
(Figure 12B). Upon agonist removal YFP intensity decreased while CFP intensity 
increased which was caused by arrestin 3 dissociation from the receptor. As seen for the 
interaction measurement of β1-AR and Gs protein, β1-AR-arrestin 3 interaction was 
disrupted during depolarization indicated by a decrease in the Iso-evoked FRET amplitude 
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(Figure 12B). Averaged data showed that the interaction of β1-AR and Arr3 evoked by 
either Iso (100 nM, Figure 12C) or Adr (1 µM, Figure 12D) was weakened by a 
depolarizing step to +45 mV. Reduction of the depolarization step from +60 mV to 
+45 mV compared to the measurements before helped to stably control the membrane 
potential over these longer-term recordings. The β1-AR-Arr3 complex disruption by 
depolarization also seemed faster than disruption kinetics by agonist withdrawal; a similar 
finding as for measurements at the receptor level and G protein-receptor interaction (6.1, 
6.1.1, 6.1.4). 
Especially in cells stimulated with Iso it was apparent that the FRET signal was not 
fully reversible after ligand washout (Figure 12B, C). This is, presumably, due to the 
accumulation of β1-AR-Arr3 complexes in clathrin-coated pits (CCPs) which prevented the 
disruption of their interaction by ligand washout. Only a fraction of receptors and arrestins 
are still able to dissociate upon ligand washout which resulted in an elevated baseline at the 
end of the measurements. The degree of recovery in Adr-stimulated cells was better than in 
Iso-stimulated cells but also incomplete (Figure 12D). A lower affinity of Adr towards β1-
AR compared to Iso resulting in faster dissociation rates allowed shorter measurement 
protocols. In a shorter time less β1-AR-Arr3 complexes could accumulate leading to a 
better reversibility of the FRET signal upon Adr washout.  
To quantify the reduction in FRET induced by depolarization, amplitudes at -90 mV 
and +45 mV were measured. The amplitudes at +45 mV were measured from the baseline 
to the ratio during depolarization in each individual measurement. At the same time-point 
the reference amplitude at -90 mV in each cell was measured: Ratio values before and after 
the depolarizing step were linearly connected (indicated by dashed lines in Figure 12C and 
D) and the -90 mV amplitude was measured between the baseline and the connecting 
straight line at the same time-point as the amplitude at +45 mV. In non-saturating 
conditions, depolarization weakened the interaction between arrestin 3 and β1-AR by about 
30% in Iso- and Adr-stimulated cells (Figure 12E). This loss of interaction was 
significantly smaller when saturating concentrations of Iso and Adr were used. When 
stimulated with 100 nM and 10 µM Iso, the depolarization effect was significantly reduced 
from 31.0±2.2% to 16.9±1.6% (p<0.001), respectively, i.e. by about two-fold. The 
weakening of interaction by depolarization dropped significantly from 32.3±1.2% to 
8.3±1.2% (p<0.001), i.e. by about a factor of four, in cells stimulated with 1 µM Adr and 
100 µM Adr, respectively. 
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Figure 12: Depolarization weakens the interaction between β1-AR and arrestin 3. 
A: To analyze the interaction of β1-AR and arrestin 3, cells were transfected with β1-AR-YFP and CFP-
labeled arrestin 3 together with non-fluorescent GRK2. Arrestin and GRK2 reside in the cytosol of 
unstimulated cells which results in low FRET. Stimulation of the receptor causes translocation of GRK2 and 
arrestin 3 to the membrane and interaction with the receptor. This agonist-induced interaction can be 
measured as an increase in FRET. As from now on FRET assays investigating this interaction between 
arrestin and the receptor will be called arrestin FRET assay or arrestin FRET. B: Opposing directions of CFP 
and YFP emission intensity due to FRET can be detected in a representative measurement upon stimulation 
of β1-AR with 100 nM Iso. Depolarization to +45 mV reduces energy transfer from CFP to YFP, resulting in 
a decrease in FRET and indicating dissociation of arrestin from the receptor. C and D: Averages±SEM of 
cells stimulated with 100 nM Iso (C: n=8) and 1 µM Adr (D: n=6) and subjected to a depolarizing pulse to 
+45 mV. The red box in D marks the section of data used for the close-up in F. E: Data points before and 
after depolarization of individual measurements under saturating and non-saturating concentrations of agonist 
were linearly connected as depicted by dashed lines in C and D. Amplitudes at rest and during depolarization 
were measured to calculate %-deactivation by depolarization (Iso: 100 nM and 10 µM, n=8; Adr: 1 µM, 
n=10 and 100 µM, n=8). Amplitudes were measured as follows: +45 mV amplitude: baseline to 
curve; -90 mV amplitude: baseline to dashed line at the same time point. The calculation of %-deactivation 
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was performed as described in Figure 9. Statistical significance was confirmed by one way ANOVA with 
Bonferroni’s multiple comparison test. ***: p<0.001. F: Measurements with saturating concentrations of Iso 
(10 µM, black trace, n=8), Adr (100 µM, red trace, n=8) and NA (100 µM, blue trace, n=8) were normalized 
to the maximal agonist-evoked FRET response prior to the depolarizing step and averaged. An overlay of the 
section indicated by the red box in B of each average is shown. The black arrow marks the time point at 
which the membrane potential was depolarized from -90 mV to +60 mV. 
The remaining effect of depolarization on β1-AR-arrestin 3-interaction induced by 
saturating agonist concentrations together with the faster deactivation kinetics upon 
depolarization again points towards an alteration in agonist efficacy during depolarization. 
This is consistent with the measurements of the β1-AR sensor and of β1-AR-G protein 
interaction and will be analyzed together in chapter 6.1.4.  
Apart from adrenaline, β1-ARs are also activated by the endogenous full agonist 
noradrenaline, which has the same affinity towards β1-AR as Adr (Bond et al., 2015). 
Arrestin 3 also interacted with the β1-AR upon stimulation with NA. Depolarization 
weakened this interaction induced by 100 µM NA (saturation) to a comparable degree as 
seen for Adr (Figure 12F). As no apparent differences in voltage-dependence between the 
two endogenous full agonists were detected, further experiments only compare the effect 
of depolarization on β1-AR stimulated with Iso and Adr. 
Depolarization-induced deactivation of β1-AR was not only detected at the receptor 
level but was also transmitted to downstream signaling. The interaction of β1-AR and 
G protein or arrestin 3 was weakened by depolarization through a reduction in agonist 
affinity and efficacy. The proportion to which reduction in affinity or efficacy contribute to 
the phenomenon of voltage-dependence will be addressed in chapters 6.1.4, 6.1.5 and 
6.1.6. 
6.1.3 Voltage-dependence occurs within the physiological range of the membrane 
potential 
As a next step it was important to determine whether the observed voltage-dependence 
of β1-AR occured within the physiological range of VM. The arrestin FRET assay was used 
to measure the relation of β1-AR-arrestin 3 interaction and VM. During stimulation with a 
non-saturating concentration of agonist, the membrane potential was switched stepwise to 
several different potentials. A representative measurement of a cell stimulated with 1 µM 
Adr showed differential alterations in the FRET amplitude induced by different potentials 
(Figure 13A). Hyperpolarization to -120 mV enhanced the interaction between β1-AR and 
arrestin 3 while stepwise depolarization gradually reduced it. The FRET amplitudes at a 
given test potential and the corresponding amplitude at -90 mV (baseline to dashed line at 
the same time point) were measured. Amplitudes were calculated as a percentage of the 
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response at -90 mV and plotted against the membrane potential. The data calculated in this 
manner were then fit to a Boltzmann equation (Figure 13B).  
 
Figure 13: Voltage-dependence of β1-AR occurs within the physiological range of membrane potential. 
A: A representative measurement of a cell transfected with the arrestin-FRET assay (inset) demonstrates how 
data for a FRET response-VM-plot were obtained. During stimulation with 1 µM Adr the membrane potential 
is switched between the holding potential of -90 mV and various other potentials. Amplitudes were measured 
during every VM-step, calculated as a percentage of the corresponding amplitude at -90 mV (measured from 
the baseline to the dashed line at the same time point) and plotted against VM (B). B: A Boltzmann equation 
was fit to the FRET response-VM-data of Iso- and Adr-stimulated cells (Iso: black, n=14, R2=0.99; Adr: gray, 
n=11, R2=0.99). Half maximal effective potentials were V50=-28±22 mV (Iso) and V50=-27±8 mV and the 
amount of charge moved was z=0.36 e0 (Iso) and z=0.49 e0 (Adr). 
The fits of Iso and Adr data yielded similar half maximal effective potentials of β1-AR-
arrestin 3 interaction (Iso: V0.5=-28±22 mV and Adr: V0.5=-27±8 mV). From the slope of a 
Boltzmann fit it is also possible to calculate the amount of charges moved across the 
membrane (“gating charge” in ion channels). These z-scores were z=0.36 e0 and z=0.49 e0 
for Iso and Adr, respectively. The z-scores indicated that one charge moved across about 
half the membrane in Adr-stimulation and a bit less in Iso-stimulation. The z-score 
corresponding to the Iso curve was comparably small due to the shallower Boltzmann 
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curve. Both the half maximal effective potential and the calculated z-scores for β1-AR 
voltage-dependence are in line with data obtained at M1AChR, M2AChR and α2A-AR 
(3.2.1 and 7.1; (Ben-Chaim et al., 2006; Navarro-Polanco et al., 2011; Rinne et al., 2013, 
2015)).  
Half maximal effective potentials for the interaction of receptors and arrestins obtained 
from the Boltzmann fit showed that voltage-dependence of the β1-AR lies within the 
physiological range of membrane potential. 
6.1.4 Off-kinetics indicate a major contribution of altered agonist efficacy to β1-
adrenoceptor voltage-dependence 
Differences in deactivation kinetics induced by depolarization compared to ligand 
withdrawal were visible in measurements on the β1-AR receptor level. They were also seen 
in measurements analyzing the interaction of the receptor with either its G protein or 
arrestin 3. If depolarization only altered ligand affinity, depolarization and washout 
deactivation kinetics should be similar. This was shown to be the case for the α2A-AR 
stimulated with noradrenaline (Rinne et al., 2013). But as this was not the case for β1-AR, 
the faster deactivation during depolarization pointed towards an alteration in ligand 
efficacy. Therefore, deactivation rates of the three FRET assays were analyzed in detail in 
order to identify the contribution of agonist efficacy to the phenomenon of voltage-
dependence.  
Altered efficacy underlying voltage-dependence has been postulated for some GPCRs 
before (Martinez-Pinna et al., 2005; Gurung et al., 2008; Navarro-Polanco et al., 2011; 
Sahlholm et al., 2011; Rinne et al., 2013). Most of these studies used indirect methods 
hardly suitable to detect alterations in efficacy because either receptor numbers or receptor 
coupling affected the measurements (Lohse et al., 2003). Only measurements with α2A-AR-
cam, the intramolecular FRET-based fusion protein of the α2A-AR, activated by clonidine 
provided direct evidence for a change in efficacy of this ligand (Rinne et al., 2013).  
Deactivation kinetics of data obtained with the β1-AR sensor (Figure 8C, D) and the 
FRET-assays measuring receptor-G protein interaction (Figure 11C, D) or receptor-
arrestin 3 interaction (Figure 12C, D) were analyzed. Dark gray and light gray boxes in the 
normalized average trace of the β1-AR-sensor indicate were off-kinetics induced by 
depolarization or ligand withdrawal were calculated, respectively (Figure 14A, data of 
Figure 8C). Mono-exponential functions were fit to the indicated sections of the average 
traces of Iso- and Adr-stimulated cells. A poor signal-to-noise ratio did not allow fitting of 
individual experiments. The quantification of koff-values yielded a 100-fold accelerated 
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deactivation by depolarization compared to washout-induced deactivation 
(koff voltage=1.7±0.5 s-1; koff washout=0.017±0.003 s-1) in cells stimulated with Iso (Figure 
14B). Compared to Iso the affinity of Adr towards β1-AR is lower. This caused faster 
washout kinetics and therefore an only about 8-fold but yet significant difference between 
deactivation kinetics by washout or by depolarization (koff voltage=0.98±0.2 s-1; 
koff washout=0.13±0.006 s-1) in Adr-stimulated cells.  
To visualize the difference in deactivation kinetics of the protein-interaction studies, the 
data corresponding to the sections indicated in Figure 14A where normalized to the 
maximal FRET effect in each individual experiment, averaged and overlaid (Figure 14C, 
E). To increase clearness, the error bars only point to one direction. The arrows mark the 
time-points at which either the cell was depolarized or the agonist was withdrawn. Already 
from these overlays it is visible, that the interaction of β1-AR either with its G protein 
(Figure 14C, 10 µM Adr) or with arrestin 3 (Figure 14E, 100 nM Iso) is disrupted more 
rapidly by depolarization than by ligand withdrawal. The quantification was done by fitting 
a mono-exponential function to the average traces as described above. The dissociation 
rate of the G protein from β1-AR upon depolarization was comparable in both Iso- and 
Adr-stimulated cells (Iso: koffvoltage=2.2±1.0 s-1; Adr: koffvoltage=2.3±0.5 s-1) (Figure 
14D) despite their different washout dissociation rates (Adr: koffwashout=0.21±0.006 s-1; 
Iso: koffwashout=0.033±0.003 s-1). This pointed towards a similar mechanism underlying 
voltage-dependence of Iso- and Adr-stimulated β1-AR. An 11-fold and a 70-fold difference 
in dissociation rate during depolarization compared to agonist withdrawal was calculated 
for Adr and Iso, respectively. Quantification of the arrestin 3 dissociation from β1-AR 
yielded 10-fold (koffvoltage=0.32±0.02 s-1; koffwashout=0.031±0.001 s-1) and about 14-fold 
(koffvoltage=1.37±0.1 s-1; koffwashout=0.099±0.002 s-1) differences in Iso- and Adr-
stimulated cells, respectively (Figure 14F). Note, the half-times of the measurements of 
G protein-receptor interaction and the β1-AR-Arr3-interaction under Adr stimulation were 
close to the detection limit of the sampling frequency used (G protein: t1/2=0.3 s, 
frequency: 5 Hz; arrestin 3: t1/2=0.5 s (Adr), frequency: 2.5 Hz). Measurement accuracy for 
the fast deactivation and disruption of interaction is therefore limited. 
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Figure 14: Deactivation kinetics suggests agonist efficacy to be the major target of voltage-dependence. 
Deactivation kinetics by agonist withdrawal or depolarization were compared for the β1-AR-sensor (A and 
B), for the interaction of receptor and G protein (C and D) and for the interaction of receptor and arrestin (E 
and F) (see insets). A: Light gray and dark gray boxes in the average trace taken from Figure 8C mark the 
sections in which off-rates were determined by fitting a mono-exponential function to the average trace. C 
and E: The data sections of Figure 11D and Figure 12C corresponding to the gray boxes in A were 
normalized to the maximal FRET amplitude and overlaid. Mono-exponential functions were fit to the 
averages to determine washout- and depolarization-induced deactivation kinetics. To maintain clearness, the 
error bars only point in one direction. Arrows in both graphs indicate the time point at which agonists were 
withdrawn or at which the membrane was depolarized. B, D, F: Summary of washout- and depolarization-
mediated koff values and statistical analysis (B: n≥8; D: n=7, F:n≥8). Statistical significance was determined 
using F-test for fit comparison. **: p<0.01, ***: p<0.001. #: Sampling rates in measurements analyzed for D 
and F were 5 Hz and 2.5 Hz, respectively. The koff values were close to the detection limit of 200 ms in D 
(both agonists) and of 400 ms in F (Adr stimulation). 
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Especially the measurements at the receptor level, but also those of the downstream 
effectors clearly showed that alterations in efficacy are involved in the phenomenon of 
voltage-dependent regulation of β1-AR activity. Furthermore, this reduction in agonist 
efficacy during depolarization exceeded the reduction in affinity (compare to results of 
Figure 9A, B and Figure 12E) and therefore seemed to be the major player in voltage-
dependent fine-tuning of the β1-AR activity.  
6.1.5 Measurements of deactivation kinetics under constant membrane potential 
show a moderate reduction in agonist affinity at depolarization 
According to the law of mass action a change in off-rate of a reaction has to be due to 
an alteration in agonist affinity provided that the on-rate of this reaction is unchanged. 
Thus, I analyzed deactivation kinetics to compare agonist affinities at a constant potential 
of either -90 mV or +45 mV. Cells were transfected with the arrestin FRET assay 
constructs, stimulated with either 100 nM Iso (Figure 15A) or 1 µM Adr (Figure 15C) and 
measured twice, once at each potential. The order of the potentials was alternated between 
measurements. Upon Iso withdrawal, Arr3 dissociated significantly faster from the 
receptor at depolarization compared to the dissociation at -90 mV (Figure 15A, B) but the 
difference in koff-values was less than two-fold (+45 mV: koff=0.044±0.005 s-1; -90 mV: 
koff=0.027±0.003 s-1) (Figure 15B). Accumulation of receptor-arrestin complexes, 
presumably in clathrin-coated pits (CCPs), again prevented a full reversibility of the FRET 
signal after prolonged washout in these measurements (Figure 15A).  
From the previous experiments with Adr a larger reduction in affinity in cells stimulated 
with Adr would be expected compared to the results obtained with Iso. But due to the fast 
dissociation of Adr from the β1-AR upon agonist washout and the therefore fast 
dissociation of Arr3 from the receptor, the additional increase in the dissociation rate 
during depolarization was hardly visible (Figure 15C). The analysis of koff-values also only 
yielded a small but significant acceleration in the dissociation rate at depolarization which 
was less than two-fold (-90 mV: koff=0.1375±0.011 s-1; +45 mV: koff=0.2044±0.030 s-1) 
(Figure 15D). Note that the FRET signal almost reversed back to baseline after Adr 
washout. This is likely due to the shorter stimulation time which led to less accumulation 
in CCPs. 
In principle, it is possible to deduce changes in agonist affinities from the evaluation of 
deactivation or dissociation kinetics if the on-rate of the reaction is unaltered (law of mass 
action). The analysis showed a slight reduction in affinity for Iso during depolarization but 
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this experiment did not prove well suited to deduce changes in Adr affinities due to its fast 
dissociation from the β1-AR even at the resting potential. 
 
Figure 15: Analysis of deactivation kinetics reveals minor reduction in agonist affinity during 
depolarization. 
A and C: Cells transfected with the arrestin FRET assay were measured twice under constant membrane 
potential of -90 mV and +45 mV in an alternating order and stimulated with 100 nM Iso (A) or 1 µM Adr 
(C). Individual measurements were normalized to the maximal agonist-evoked FRET response 
(average±SEM, A: n=9; C: n=10). B and D: Comparison of deactivation kinetics (koff) during depolarization 
and at rest of the measurements stimulated with Iso (B) and Adr (D). Statistical analysis was performed with 
paired student’s t-tests. ***: p<0.001, *: p<0.05. 
6.1.6 Efficacy essentially contributes to Iso-stimulated β1-adrenoceptor voltage-
sensitivity: A concentration-response curve  
In order to compare the involvement of alterations in affinity and efficacy to voltage-
dependence of the β1-AR activity directly in a classical pharmacological way, data were 
collected to plot concentration-response curves for Iso at the resting potential (-90 mV) and 
at depolarization (+45 mV). Because of its good signal-to-noise ratio and the reliably large 
amplitudes, the arrestin FRET assay was used for this task. Transfected cells were 
stimulated twice: first with an Iso test concentration and after washout with the reference 
concentration of 10 µM Iso. During both stimulations the membrane potential was 
switched between -90 mV and +45 mV (Figure 16A). Two-point interpolations (dashed 
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lines) were used to adjust the baselines, which increased due to accumulation of receptor-
arrestin-complexes. Amplitudes were measured between the dashed lines and the FRET 
trace at depolarization (A+45) or at rest (A-90) during stimulation with the test concentration. 
These amplitudes were normalized to the reference amplitude (Aref) at -90 mV during 
stimulation with 10 µM Iso in each cell (A+45/Aref or A-90/Aref) to allow the comparison of 
FRET amplitudes between cells independently of the absolute agonist-induced FRET 
response of individual measurements. The averages of these normalized FRET responses 
were plotted against the Iso concentration (Figure 16B). Data for 10 µM Iso were collected 
in the same way as for the other test concentrations: First, 10 µM Iso were applied and 
withdrawn as the test concentration before the second application of 10 µM Iso was 
administered as a reference. Note, that the data points at concentrations of 1 µM Iso and 
higher exceed the 100% reference value. These high concentrations of Iso induced a fast 
accumulation of arrestin-receptor complexes. As a result, the fraction of available arrestins 
and receptors for the second stimulation was reduced which resulted in a steep rise of the 
curve during the first stimulation and comparatively smaller amplitudes during the second 
one. Paired student’s t-tests confirmed significant differences in the FRET response at 
+45 mV compared to -90 mV of each test concentration except 10-10 M Iso. Sigmoidal 
functions allowing a variable Hill slope were fit to the data collected at -90 mV and at 
+45 mV. The difference between EC50-values of the curves at -90 mV (EC50=2.5*10-8 M) 
and at +45 mV (EC50=4.8*10-8 M) did not reach statistical significance. In contrast, the 
maximal FRET response at depolarization was significantly lower than the maximal 
response at the holding potential (Max+45=1.02, Max-90=1.17; p=0.0066, F-test for fit 
comparison).  
This concentration-response curve for Iso confirmed the findings described previously: 
Mostly a reduction in efficacy underlies the voltage-dependent regulation of Iso-induced 
β1-AR activity whereas a reduction in affinity is only a minor contributor. 
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Figure 16: Comparison of concentration-response curves for Iso at two potentials identifies efficacy as 
the major contributor of voltage-dependence. 
A: A representative arrestin FRET assay measurement shows how data for the concentration-response curves 
were collected. Cells were stimulated with a test concentration of Iso (here 1 µM). After washout of the test 
concentration, a second stimulation with the reference concentration of 10 µM followed. The membrane 
potential was switched from -90 mV to +45 mV during both stimulations. A two-step interpolation between 
data points at rest before and after stimulation was used to adjust the baseline for data analysis (dashed lines). 
Amplitudes A+45 and A-90 of each test concentration were set in relation to Aref of the same measurement. B: 
The normalized FRET amplitudes at both potentials were plotted against the Iso concentrations and fit to a 
concentration-response function (n=3-9 per data point, -90 mV: EC50=2.5*10-8 M; +45 mV: 
EC50=4.8*10-8M; Max-90=1.17, Max+45=1.02,; p=0.0066) Paired student’s t-tests or F-test were used to 
determine statistical differences in FRET amplitudes at rest and depolarization at the tested Iso 
concentrations or in EC50s and the maximal values of the fit curves, respectively. 
6.1.7 β1-adrenoceptor voltage-dependence is agonist specific 
The data collected so far suggested agonist specific differences between Iso and Adr 
regarding β1-AR voltage-sensitivity: A reduction in agonist affinity by depolarization 
seemed more pronounced in Adr- than in Iso-stimulated cells at the receptor level whereas 
the change in efficacy was comparable for both agonists (Figure 9A, B). A differential 
voltage-sensitivity depending on the agonist used for stimulation has also been reported for 
example for the M2AChR (Navarro-Polanco et al., 2011) and D2SR (Sahlholm et al., 
2008b). While pilocarpine-activated M2AChRs were further activated during 
depolarization, the activity of receptors activated by acetylcholine was reduced at a 
positive membrane potential. GIRK currents induced by dopamine-stimulation of D2SRs 
decreased during depolarization. However, when the receptors were stimulated with 
agonists like β-phenethylamine, p- or m-tyramine, depolarization did not alter agonist-
evoked GIRK currents.  
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Figure 17: Chemical structure of the natural and synthetic full and partial agonists of β1-AR used in 
this study. 
The red circles in the dopamine and dobutamine structures mark the lack of a β-hydroxyl-group. DA: 
dopamine, NA: noradrenaline, Adr: adrenaline, Iso: isoprenaline, DOB: dobutamine. 
In order to investigate agonist-specificity of voltage-dependence more closely for the 
β1-AR, we used two different partial agonists to stimulate cells transfected with the arrestin 
FRET assay constructs. The first partial agonist was dobutamine (DOB), a structural 
analogue of isoprenaline which was developed to selectively increase cardiac contractility 
(Tuttle and Mills, 1975). The second was dopamine (DA), the simplest catecholamine and 
a precursor in the synthesis of NA and Adr. Both partial agonists lack the β-OH-group 
present in the endogenous agonists Adr and NA and the synthetic catecholamine Iso (red 
circle, Figure 17). 
Cells were stimulated with dobutamine and adrenaline in order to estimate the maximal 
effect that can be induced by this partial agonist. Stimulation with 10 µM and 100 µM 
dobutamine induced β1-AR-Arr3-interaction to almost the same degree which was, as 
expected, smaller than the full activation by 100 µM Adr (Figure 18A). The maximal 
dobutamine effect was 38±1% of the maximal Adr-evoked FRET response. Depolarization 
of dobutamine-stimulated cells reversibly diminished β1-AR-Arr3-interaction as seen in 
cells stimulated with Adr, NA or Iso (Figure 18B).  
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Figure 18: Voltage-dependence of the partial agonist dobutamine. 
The arrestin FRET assay was used to investigate voltage-dependence of dobutamine-activated β1-AR. 
Individual experiments were normalized to the initial FRET value prior to the first stimulation before 
averaging. A: The maximal FRET response by dobutamine (10 µM and 100 µM) relative to full stimulation 
with Adr (100 µM) was determined in unpatched cells (average±SEM, n=4, one transfection only). B: 
Voltage-dependence of dobutamine-induced β1-AR-Arr3-interaction was measured in cells stimulated with 
100 µM dobutamine (average±SEM, n=8). 
In unpatched cells, FRET measurements were performed to estimate an EC50-value for 
the β1-AR-arrestin 3 interaction induced by dopamine in the context of a 
Wahlpflichtpraktikum. Cells were stimulated with increasing concentrations of dopamine 
ranging from 1 µM to 1 mM without washout between the applications. Individual 
measurements were normalized to their initial value prior to stimulation with the first 
concentration of dopamine and then averaged (Figure 19A). It can nicely be appreciated 
from this overlay that the FRET signal increased stepwise in a concentration-dependent 
manner. The very fast disruption of interaction upon dopamine withdrawal indicated its 
low affinity to the β1-AR. Agonist-evoked FRET responses were normalized to the 
maximal FRET response induced by 1 mM dopamine in each measurement and plotted 
against the dopamine concentration (Figure 19B). A sigmoidal curve fit to the data yielded 
an EC50 of 4.2*10-4 M dopamine. This result was similar to earlier reports of the affinity of 
dopamine towards β1-ARs obtained from whole-cell binding experiments on CHO cells 
stably expressing β1-AR in which a KD value of -3.57±0.02 (EC50=2.7*10-4 M) was 
determined (Baker, 2010). To estimate the maximal FRET response which can be induced 
by the partial agonist dopamine compared to the full agonist Adr, cells were stimulated 
with increasing concentrations of dopamine. Following application of the highest 
dopamine concentration, 100 µM Adr were applied (Figure 19C). The dopamine-induced 
FRET response with 300 µM DA reached a maximum at about 37% of the maximal FRET 
response induced by 100 µM Adr.  
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Figure 19: Concentration-dependent activation of β1-AR by dopamine. 
Cells were transfected with constructs of the arrestin FRET assay to investigate dopamine-mediated 
activation of β1-AR. All individual measurements were normalized to the FRET value prior to stimulation 
before averaging. A: Data for a concentration-response curve were collected in FRET measurements with 
dopamine concentrations ranging from 1 µM to 1 mM (average±SEM, n=11). B: FRET amplitudes were 
normalized to the maximal FRET amplitude at 1 mM DA in each measurement, plotted against the DA 
concentration and fit to a concentration-response function (EC50=4.2*10-4 M). C: Cells were stimulated with 
increasing concentrations of DA followed by stimulation with 100 µM Adr to estimate the maximal inducible 
FRET response by the partial agonist DA (average±SEM, n=5, one transfection only).  
With a concentration of 100 µM dopamine the voltage-dependence of dopamine-induce 
β1-AR-arrestin 3 interaction was determined. During stimulation with 100 µM dopamine 
the membrane potential was switched to +45 mV and back to the holding potential before 
ligand washout (Figure 20A). Interestingly, depolarization further enhanced β1-AR-Arr3 
interaction indicated by an increase in ratio during depolarization which was reversible 
upon repolarization. A predicted difference in binding of dopamine (Figure 20B) to β2-AR 
compared to Iso (Figure 20C) (Katritch et al., 2009) could underlie this difference in 
direction of voltage-sensitivity. The Iso β-OH group is engaged in a hydrogen bond with 
the conserved D3.32 (D113 in β2-AR) in TM3 which is important for ligand binding (Figure 
20C, indicated by cyan dotted lines). As dopamine lacks this β-hydroxyl group and does 
not interact with the D3.32 at this position, it is slightly rotated within the binding pocket 
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compared to Iso (Figure 20B). This results in a binding mode that does not involve a 
hydrogen bond between the catechol meta-OH-group and N6.55 (N293 in β2-AR) in TM6 
which is present when Iso is docked into β2-AR (compare Figure 20B and C, (Katritch et 
al., 2009)). Similarly, in muscarinic receptors the binding mode of a ligand within the 
binding pocket also influenced direction of voltage-dependence (Rinne et al., 2015). 
M3AChR activity induced by ligands like carbachol (CCh) or ACh interacting with a TM6 
asparagine (N6.52) was reduced during depolarization. When the receptor was stimulated 
with pilocarpine which favors an orientation towards D3.32, depolarization further enhanced 
receptor activity (Rinne et al., 2015).  
A 
 
 
B 
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Figure 20: Depolarization increases the interaction between β1-AR and arrestin 3 in the presence of 
dopamine. 
A: Cells were transfected with constructs of the arrestin FRET assay to investigate voltage-dependence of 
dopamine-activated β1-AR. Individual measurements were normalized to the FRET value prior to stimulation 
before averaging. Voltage-dependence of DA-induced receptor-arrestin interaction was assessed in cells 
stimulated with 100 µM DA and depolarized to +45 mV (average±SEM, n=9). B and C: Representations of 
the predicted binding modes of dopamine (B) and Iso (C) to a flexible side chain β2-AR model were extracted 
and slightly modified from (Katritch et al., 2009). Agonists are depicted as yellow sticks and carbon atoms. 
Cyan dotted lines indicate hydrogen bonds between the ligands and the receptor. Oxygen and nitrogen atoms 
of the ligands are colored red and blue, respectively. 
Similar to Iso, dobutamine binding to the structure of β1-AR also involves a hydrogen 
bond between the catechol meta-hydroxyl group and the TM6 aspartic acid N6.55 (Warne et 
al., 2011) which could explain the same direction of voltage-dependence despite a lack of 
the β-OH group. 
Taken together these data show that the activity of β1-AR induced by the partial 
agonists dopamine and dobutamine was voltage-dependent. This voltage-dependence, 
however, was of opposite direction. The interaction of β1-AR and Arr3 was weakened in 
the presence of dobutamine whereas it was strengthened in the presence of dopamine 
during depolarization. Different binding modes of these agonists within the binding pocket 
favoring an orientation towards N6.55 or D3.32 might account for agonist-specificity of 
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voltage-dependence and would be in agreement with the data published for muscarinic 
receptors. 
6.2 Voltage-dependence of β2-adrenoceptors 
An over 70% sequence homology in the transmembrane regions exists between the 
human β1-AR and the human β2-AR (Frielle et al., 1989). It was therefore interesting to 
investigate whether the activity of human β2-ARs can also be modulated by the membrane 
potential.  
 
Figure 21: Voltage-dependence of β2-AR activity is less pronounced than in β1-AR. 
A and B: A HEK 293 cell line stably expressing an intramolecular FRET-based β2-AR fusion protein (β2-AR-
sensor) (Ahles et al., 2011) was stimulated with 100 nM Iso (A) or 1 µM Iso (B) to investigate its voltage-
dependence. Single experiments were corrected for bleaching, normalized to the initial FRET value prior to 
agonist application and smoothed. A depolarizing step to +60 mV was performed during stimulation with Iso 
(average±SEM, A: n=4, B: n=4). 
With a human β2-AR FRET-based intramolecular fusion protein (β2-AR sensor) similar 
to the β1-AR sensor, I aimed to explore β2-AR voltage-sensitivity. This construct and 
HEK 293 cells stably expressing it were kindly provided by Prof. Dr. Stefan Engelhardt 
(cloning of the construct is described in (Ahles et al., 2011)). An eYFP is inserted into the 
β2-AR third intracellular loop and CFP is fused to its C-terminus which enables monitoring 
of receptor conformational changes as a ratio decrease. Stimulation of the stably 
transfected HEK 293 cells with 100 nM Iso decreased the initial ratio indicating receptor 
activation. This decrease was reversible after agonist washout (Figure 21A). Due to 
photobleaching and a poor signal-to-noise ratio, the individual experiments were corrected 
for bleaching and smoothed before averaging. Depolarization to +60 mV only slightly 
reduced the Iso-evoked FRET response by an extent hardly above the noise of the average 
trace (Figure 21A). When cells were stimulated with 1 µM Iso, depolarization was not able 
to induce any deactivating conformational changes (Figure 21B).  
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These initial experiments suggested that the voltage-dependence of β2-AR is difficult to 
detect with this intramolecular FRET sensor and voltage-dependence seemed to be less 
pronounced than in β1-AR. Due to the better signal-to-noise ratio, experiments measuring 
arrestin 3 interaction with β2-AR by means of FRET seemed more suitable to investigate 
β2-AR voltage-dependence. 
6.2.1 Minor reduction of agonist-induced β2-AR-Arr 3-interaction by depolarization 
To elaborate on the voltage-sensitivity of β2-AR by means of a FRET assay with 
consistently large FRET responses and a good signal-to-noise ratio, cells were transfected 
with the plasmids encoding for a human YFP-labeled β2-AR (β2-AR-YFP), CFP-Arr3 and 
unlabeled GRK2 (Krasel et al., 2005). 
 
Figure 22: β2-AR-arrestin 3-interaction is slightly decreased during depolarization. 
A and B: Cells transfected with β2-AR-YFP, CFP-Arr and non-fluorescent GRK2 were stimulated with non-
saturating (A) or saturating (B) concentrations of agonist. A: Single experiments were normalized to the value 
prior to stimulation with 100 nM Iso (average±SEM, n=9). B: For better comparison of the depolarization 
effect on receptor-arrestin-interactions induced by 100 µM Adr (red) or 10 µM Iso (black), individual 
measurements were normalized to the maximal agonist-evoked FRET amplitude before the depolarizing step 
(average±SEM, Adr: n=8; Iso: n=7). 
Stimulation with 100 nM Iso activated the β2-AR which led to its phosphorylation by 
GRK2 followed by the recruitment of and interaction with Arr3 which could be monitored 
by an increase in FRET. A depolarizing pulse to +45 mV only slightly reduced the Iso-
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induced FRET amplitude (Figure 22A). The average reduction of interaction by 
depolarization was 9.9±1.1%. In cells stimulated with saturating concentrations of Iso 
(10 µM) or Adr (100 µM), depolarization-induced disruption of receptor-arrestin-
interaction was hardly visible or absent, respectively (Figure 22B). To compare the effects 
in Iso- and Adr-stimulated cells, the individual experiments were normalized to the 
maximal agonist-induced FRET response before the depolarizing pulse.  
These data indicate that voltage-dependence of β2-AR activity is less pronounced than 
β1-AR voltage-dependence. The absence of a depolarization-dependent inhibition of β2-
AR-Arr3-interaction in agonist saturation suggests that the β2-AR voltage-dependence is 
likely achieved through a reduction in agonist affinity.  
6.3 Voltage-dependence of α2A-adrenoceptor 
Voltage-dependence of α2A-AR activity at the receptor level as well as its transmission 
to G protein activation, arrestin 3 interaction and GIRK channel activation has been 
described thoroughly (Rinne et al., 2013). In the same study, concentration-response 
curves for noradrenaline were measured with an intramolecular FRET-based α2A-AR 
fusion protein (α2A-cam) at a holding potential of -90 mV and at depolarization (+60 mV). 
An about six-fold increase in the EC50-value at depolarization suggested a reduction in 
affinity underlying voltage-dependence of NA-stimulated α2A-AR.  
6.3.1 Determination of voltage-dependent radio-ligand binding to α2A-adrenoceptors 
expressed in Xenopus laevis oocytes 
In order to show reduced agonist binding to the receptor at depolarization, I measured 
direct binding of tritium-labeled noradrenaline ([3H]-NA) to α2A-AR at two different 
potentials in X. laevis oocytes in the laboratory of Dr. Hanna and the late Dr. Itzchak 
Parnas. Oocytes were injected with cRNA encoding for α2A-AR together with cRNA for 
the GIRK-channel subunits 1 and 2 one day after oocyte preparation. Control oocytes, 
which were used to measure unspecific binding of the radio-ligand, were not injected with 
cRNA. Four to five days after injection, noradrenaline-dependent GIRK currents were 
measured using standard two-electrode voltage-clamp to ensure sufficient expression of 
α2A-AR. If the basal GIRK current was enhanced by NA-stimulation, the remaining 
injected oocytes were used for radio-ligand binding measurements. One oocyte at a time 
was first incubated in [3H]-NA solution for 30 s or 60 s, then washed for two seconds in a 
specialized washing chamber to remove the unbound hot ligand and then transferred into 
vials containing scintillation liquid (5.3.1.4 or (Ben-Chaim et al., 2003)). Oocytes were 
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either incubated with hot ligand in solutions containing high potassium concentrations 
(high K+, HK, about 5 mV) to mimic depolarization or solutions resembling the 
extracellular solution (ND96, about -88 mV) for the resting state of the membrane 
potential. Oocytes for specific and unspecific binding were measured alternately.  
 
Figure 23: Binding of [3H]-NA to Xenopus laevis oocytes expressing α2A-AR. 
X. laevis oocytes were injected with cRNA for α2A-ARs and the subunits 1 and 2 of GIRK channels 4-5 days 
before the experiment. Control oocytes to detect non-specific binding (ns) were injected with GIRK subunits 
only. Two different membrane potentials were achieved using buffers with different potassium 
concentrations (see methods). A: Oocytes were incubated with 300 nM [3H]-NA in either ND or HK buffer 
for 60 s before washing and measuring in a scintillation counter (ND: n=6 (total); n=7 (ns); HK: n=8(total), 
n=6 (ns)). B: Specific binding was determined as the difference between total (total ND, total HK) and 
unspecific binding (ns ND, ns HK) at both potentials. C: Oocytes were incubated with 700 nM [3H]-NA in 
either ND or HK buffer for 30 s before washing and measuring in a scintillation counter (ND: n=8 (total); 
n=8 (ns); HK: n=6(total), n=6 (ns)). D: Quantification of the specific binding calculated as in B. Statistical 
significance within the ND and HK groups and between columns of specific binding was tested with 
unpaired student’s t-tests. ***: p<0.001, **: p<0.01, *: p<0.05, ns=non-specific binding. 
Unfortunately, only in two experiments a significant difference between total and 
unspecific binding at rest and at depolarization could be detected (Figure 23). The first 
experiment was performed with a 300 nM [3H]-NA solution and an incubation time of 
60 s. The total binding at rest was of 6161±470 dpm and of 4520±350 dpm in the high 
potassium solution, i.e. at depolarization (Figure 23A). Both conditions showed low 
unspecific binding to uninjected control oocytes. Specific binding, i.e. the difference 
between total and unspecific binding, was calculated to be 4137±470 dpm for cells in 
ND96 solution, i.e. at rest, and 2876±350 dpm at depolarization. These count numbers at 
rest and depolarization were significantly different (Figure 23B). A second set of data with 
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significant differences between total and unspecific binding in the conditions at rest and at 
depolarization was measured with a NA concentration of 700 nM and an incubation time 
of 30 s (Figure 23C). Calculation of specific binding showed a tendency of lower specific 
binding at depolarization, however, the difference between 1834±440 dpm (ND96) and 
963±270 dpm was not statistically significant (p=0.146) (Figure 23D). 
To depolarize the cells in the binding assay without the need of electrophysiological 
equipment, the potassium concentration was increased on the expense of the sodium 
concentration in order to maintain the same osmolarity in both the ND and the HK 
solutions. Measurements by Prof. Andreas Rinne, however, showed that the concentration 
of sodium is critical for the agonist affinity at the α2A-AR. The EC50 increased from 
0.8 µM NA in the presence to 19 µM NA in the absence of sodium (unpublished data by 
Prof. Rinne). These findings concur with measurements on the sodium-dependence of 
agonist binding to cell homogenates of mouse mammary tumor cells stably expressing the 
human α2A-AR (Pihlavisto et al., 1998).  
Whether the decrease in radio-ligand binding measured in the oocytes resulted from 
depolarization of the plasma membrane or the reduction in sodium concentration from 
96 mM (ND solution) to 2 mM (HK solution) is therefore difficult to answer.  
6.3.1.1 Measurement of α2A-adrenoceptor densities in cell membranes of transiently 
transfected HEK 293 cells  
For a different project I measured α2A-AR densities in cell membranes of HEK 293 cells 
transiently transfected with cDNAs for α2A-AR along with the cDNA for adenylyl cyclase 
type 5 and for the epac1-camps FRET-sensor (Nikolaev et al., 2004; Reddy et al., 2015). 
Binding of [3H]-clonidine (700 nM) to membranes prepared from three different 
transfections were measured in triplicates against binding to membranes of transfected 
cells in the presence of yohimbine and to untransfected control cells. A slower off-rate of 
clonidine from α2A-AR due to its higher affinity towards the receptor compared to NA 
(Jasper et al., 1998) facilitated the measurements. Untransfected controls did not show any 
specific radio-ligand binding. The average density of the α2A-AR in three preparations was 
10.98±0.9 pmol/mg membrane protein.  
6.3.2 Depolarization reduced α2A-adrenoceptor-arrestin 3-interaction evoked by 
adrenaline but not by noradrenaline in saturation 
The former studies on the voltage-dependence of α2A-AR activity have been conducted 
with the ligands noradrenaline or clonidine (Figure 23, radio-ligand binding on HEK cells 
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and (Rinne et al., 2013)). As there were agonist-specific differences at the β1-AR and 
between NA- and clonidine-stimulated α2A-AR (Rinne et al., 2013), I also tested for 
voltage-dependent regulation of adrenaline-evoked α2A-AR activity. Cells were either 
stimulated with a saturating concentration of NA (100 µM) or Adr (100 µM). While 
depolarization did not disrupt receptor-arrestin interaction induced by NA, it was able to 
reduce the interaction in Adr-stimulated cells (Figure 24A). For better visualization of the 
depolarizing-effect on NA- and Adr-stimulated cells, the experiments were normalized to 
the maximal agonist-evoked FRET response before the depolarizing step. To make sure 
that stimulation with 100 µM Adr fully saturated the receptor, unpatched cells were 
stimulated with 100 µM and 300 µM Adr in FRET measurements (Figure 24B). No 
additional recruitment of and interaction with arrestin 3 was induced in the presence of the 
higher Adr concentration.  
 
Figure 24: Voltage-dependence of α2A-AR-arrestin 3-interaction shows agonist-specificity. 
The interaction of α2A-AR and arrestin 3 was monitored using the following FRET constructs: α2A-AR-YFP, 
CFP-Arr, GRK2. A: Measurements of receptor-arrestin interaction stimulated with 100 µM NA (black, n=6) 
or 100 µM Adr (red, n=10) were normalized to the maximal agonist-evoked FRET response before 
depolarization to +45 mV before averaging (average±SEM). B: To ensure that 100 µM Adr in A fully 
saturated the FRET assay, unpatched cells expressing the same constructs were stimulated with 100 µM Adr 
followed by the stimulation with 300 µM Adr (average±SEM, n=12). 
Depolarization-mediated differences between NA- and Adr-activated cells also argue in 
favor of agonist-specificity of α2A-AR voltage-dependence. Voltage-dependence of NA-
induced receptor activity seemed to be purely dependent on a reduction in agonist affinity 
consistent with the earlier report (Rinne et al., 2013). However, an alteration in agonist 
efficacy could play a role in the voltage-dependence of Adr-activated α2A-AR. But the 
contribution of reduction in Adr affinity versus efficacy during depolarization remains to 
be determined.  
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6.4 How do G protein-coupled receptors “sense” changes in the membrane 
potential?  
During the last decade, more and more GPCRs of different classes have been shown to be 
voltage-dependent (for example (Ben-Chaim et al., 2003; Martinez-Pinna et al., 2005, 
2010; Ohana et al., 2006; Sahlholm et al., 2008c; Rinne et al., 2013)). However, the 
mechanism how the membrane potential alters receptor conformation and thereby its 
activation remains unidentified. Two approaches have been used in this study in the 
attempt to elucidate the underlying mechanism: First, via changes in extracellular surface 
charge and second, via site directed mutagenesis.  
6.4.1 Increase in extracellular surface charge did not alter voltage-dependent 
behavior of α2A-adrenoceptor activity 
One possibility of how the membrane potential could influence receptor conformation 
would be via an alteration of the ion composition on the outer or inner surface of the 
plasma membrane. In order to alter the extracellular surface charge and composition, 
normal FRET buffer was replaced by a FRET buffer containing 20 mM MgCl2 (high Mg2+ 
buffer) instead of the usual 1 mM. To be able to compare measurements with high and 
normal Mg2+-concentration, FRET buffer was supplemented with 60 mM glucose (glucose 
buffer) to adjust the osmolarity and served as the control buffer.  
Stably expressed α2A-AR-cam was stimulated with 10 µM NA dissolved either in the 
glucose or the high Mg2+ buffer (Figure 25). In the absence of noradrenaline neither the 
high Mg2+ nor the glucose buffer induced any changes in the ratio. The degree of agonist-
induced reduction in the ratio and its recovery after NA withdrawal was similar in cells 
measured in either buffer condition (Figure 25A). Depolarization-induced reduction of the 
NA-evoked FRET response in the presence of high or normal extracellular Mg2+ 
concentrations was virtually identical (Figure 25B). Also hyperpolarization from -90 mV 
to -120 mV did not change the agonist-evoked FRET response regardless of the 
extracellular Mg2+ concentration (Figure 25C).  
Changes in the extracellular surface charge by addition of a high concentration of 
MgCl2 did not alter voltage-dependence of NA-activated α2A-ARs.  
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Figure 25: Manipulation of the outer surface charge does not alter voltage-sensitivity of α2A-AR-cam. 
The outer environment of HEK 293 cells stably expressing an intramolecular FRET-based α2A-AR-fusion 
protein (α2A-cam, (Vilardaga et al., 2003)) was altered with an external buffer containing a high Mg2+ 
concentration (20 mM). As a control normal FRET buffer was augmented with 60 mM glucose to equalize 
osmolarity of the two buffers. A: The same protocol was used for measurements with high external 
magnesium (red, n=6) and normal FRET buffer with glucose (black, n=5). Individual traces were corrected 
for bleaching and normalized to the initial FRET value prior to stimulation with 10 µM NA. In measurements 
either magnesium concentration, noradrenaline was solved in the same buffer (averages±SEM). B: 
Normalization of the data in A to the maximal agonist-evoked response facilitates the comparison of the 
degree of depolarization-induced receptor deactivation. C: Cells were stimulated with 10 µM NA in either 
high or normal magnesium concentration containing buffer and hyperpolarized from the holding potential of 
-90 mV to -120 mV. Individual experiments were normalized to the maximal NA-induced FRET response 
prior to the hyperpolarizing step (average±SEM; red: high magnesium, n=5; black: normal magnesium, n=4). 
6.4.2 Site-directed mutagenesis was used to identify amino acids involved in voltage-
sensing 
Voltage-gated ion channels sense changes in the membrane potential with a voltage-
sensor containing several basic amino acids, the S4-segment (Bezanilla, 2000). However, a 
voltage-sensor similar to the S4-domains in voltage-sensitive ion channels is not present in 
GPCRs. Several mutational studies have been performed but the GPCR voltage sensor has 
not yet been identified (see for example (Ben-Chaim et al., 2006; Navarro-Polanco et al., 
2011; Sahlholm et al., 2012)). In this study, the α2A-AR has been mutated by the 
QuickChange site-directed mutagenesis method in order to find the GPCR voltage-sensor.  
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6.4.2.1 Mutation of an amino acid involved in ligand binding  
A point mutation has been inserted into the wild-type α2A-AR-cam at an important 
position for ligand binding. The replacement of serine 2045.46 by alanine (S204A), a 
residue involved in ligand binding through its interactions with the para-hydroxyl group of 
the phenyl ring of catecholamines (Figure 20B and C, (Wang et al., 1991), was supposed to 
abolish receptor activation by noradrenaline. Receptor activation upon binding of the 
agonist UK1403 should remain intact. However, stimulation with a high concentration of 
noradrenaline (100 µM) still induced an agonist-dependent conformational change in the 
α2A-AR-cam in a pilot experiment (Figure 26). Due to the high concentration of agonist, a 
reduction of the NA-induced FRET amplitude by depolarization was not likely. As this 
mutant preserved its ability to bind NA, it was not investigated further.  
 
Figure 26: Mutagenesis of an amino acid involved in ligand binding.  
The α2A-AR-S204A-cam was constructed using site-directed mutagenesis. Stimulation with 100 µM NA of 
three cells transiently transfected with the construct activated the receptor mutant reversibly represented in 
this individual experiment (one of three measurement performed). The acceptor-over-donor ratio was 
corrected for bleaching and normalized to the initial values before agonist stimulation. A depolarizing step to 
+60 mV was performed during NA-stimulation.  
6.4.2.2 Neutralizing mutations of charged amino acids 
Ben-Chaim and colleagues were first able to measure ‘gating currents’ in M1AChR- and 
M2AChR-expressing Xenopus oocytes (Ben-Chaim et al., 2006). It is therefore plausible 
that charged amino acids could function as voltage-sensors and move through the electrical 
field of the membrane during depolarization generating gating currents. About 10% of the 
amino acids residing in the TM domains of the α2A-AR are charged at physiological pH 
(Vroling et al., 2011) and only few of these charged amino acids within the TM domains 
are highly conserved among class A GPCRs (Suwa et al., 2011).  
One aspartic acid conserved among biogenic amine receptors is D3.32 (Gether, 2000) 
which is also important for ligand binding. Its mutation to alanine (D113A) in the α2A-AR-
cam resulted in the loss of NA-induced receptor activation and could therefore not be 
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investigated in terms of voltage-dependence (unpublished data acquired during my 
diploma thesis).  
 
Figure 27: Charge neutralization of lysine 103 does not alter voltage-dependence of α2A-AR activity. 
Lysine 103 in the extracellular half of TM3 was replaced by alanine to neutralize the positive charge using 
site-directed mutagenesis. The resulting α2A-AR-K103A-cam construct was expressed transiently and 
stimulated with 10 µM NA and depolarized to +60 mV during the stimulation. The resulting single 
experiment was corrected for bleaching and normalized to its initial FRET value prior to stimulation. 
A charged amino acid, lysine 103, in the vicinity of this important aspartic acid was 
then mutated (K103A). It is located within the extracellular half of TM3 and points 
towards the cytoplasm (Vroling et al., 2011). Stimulation of the α2A-AR-K103A-cam with 
10 µM NA activated the receptor which was reversible upon withdrawal of the agonist 
(Figure 27). In this pilot experiment the depolarization-induced deactivation of the α2A-
AR-K103A-cam was comparable to the wild-type α2A-AR-cam. No further measurements 
were conducted with this mutant as the lysine at position 103 did not seem to be a part of a 
voltage-sensor in α2A-adrenoceptors.  
6.4.2.3 Introduction of an additional charge near the highly conserved D2.50 
increased agonist affinity 
Another highly conserved aspartic acid among class A GPCRs is D2.50 in TM2 (D79 in 
α2A-AR) (Gether, 2000). It is involved in a hydrogen bond network that connects 
transmembrane domains one, two and seven (Okada et al., 2002; Angel et al., 2009) and is 
also involved in the coordination of a sodium ion (Liu et al., 2012). This aspartic acid has 
been mutated to an alanine in M2AChR which then failed to exhibit gating currents likely 
due to a low expression of the mutant receptor (Navarro-Polanco et al., 2011).  
When the corresponding aspartic acid (D79) was mutated to alanine in the α2A-AR-cam, 
voltage-dependence was not detectable and the affinity for NA was reduced by more than 
10-fold (unpublished data by Prof. Rinne).  
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As the mutation of the conserved D79 resulted in a dramatic reduction in agonist 
affinity, we introduced a positive charge in close proximity to the negatively charged D79 
as a countercharge. We aimed to alter voltage-dependence without losing agonist affinity 
due to the removal of D79. Anna-Lena Krett mutated leucine 75, a residue one helical turn 
beneath D79 in TM2 (Figure 28A), to lysine (L75K) by site-directed mutagenesis. 
Depolarization deactivated both wild-type α2A-AR-cam and α2A-AR-L75K-cam but to a 
different degree which was nicely visible after normalization to the maximal agonist-
evoked FRET response (Figure 28B). The overlay also showed a pronounced difference in 
receptor deactivation after NA withdrawal. The mutant receptor sensor deactivated very 
slowly compared to the wild-type α2A-AR-cam indicating that the introduction of the 
positive charge near D2.50 increased the affinity for NA. To confirm this increase in agonist 
affinity, unpatched cells expressing either the wild-type or the mutant α2A-AR-L75K-cam 
were stimulated with increasing concentrations of noradrenaline in order to plot 
concentration-response curves (Figure 28C). NA-evoked responses were normalized to the 
reference concentration of 100 µM NA and plotted against the NA concentration. The 
concentration-response curve for the L75K-cam showed a left shift compared to the wild-
type receptor by a factor of approximately five (EC50L75K=0.22 µM; EC50wt=1.04 µM) 
(Figure 28C). In addition, deactivation kinetics after withdrawal of 100 µM NA were 
analyzed in unpatched cells expressing either wild-type or mutant α2A-AR-cam. Also here 
deactivation of the mutant receptor was clearly slower than wt α2A-AR-cam deactivation 
(Figure 28D). On average, koff-values of mono-exponential curves fit to the individual 
traces were about 3-fold lower in the mutant (koff=0.06±0.01 s-1) compared to the wild-type 
receptor (koff=0.16±0.02 s-1).  
When cells expressing wild-type-α2A-AR-cam were stimulated with 10 µM NA, the 
depolarizing effect on receptor deactivation was reduced compared to the stimulation with 
lower concentrations as reported (compare black traces in Figure 28B and E; (Rinne et al., 
2013)). The α2A-AR-L75K-cam could not be deactivated by depolarization anymore during 
stimulation with 10 µM NA (Figure 28E). 
Results 
73 
 
Figure 28: Insertion of an additional charge near D2.50 increases receptor affinity towards NA. 
A: The schematic shows the highly conserved D79 in TM2 and the site of mutation from the wild-type (wt) 
residue leucine (left) to a lysine (right) in the α2A-AR-L75K-cam. The black backbone structure depicts the 
TM2 α-helix. Measurements were conducted in cells transiently expressing either the wt- or the L75K-cam 
variant of the α2A-AR. All individual experiments were corrected for photo bleaching. B: To compare the 
effect of depolarization on receptor activity of wt or mutant α2A-AR, cells were stimulated with 100 nM NA 
and subjected to a depolarizing step to +60 mV. Individual measurements were normalized to the maximal 
agonist-induced FRET response prior to depolarization (average±SEM; wt: black, n=5; L75K: red, n=8). C: 
To collect data for a concentration-response curve wt- and L75K-cam were stimulated with different 
concentrations of NA. The NA-evoked FRET response was normalized to the FRET response evoked by 
100 µM NA in individual experiments. The normalized responses were plotted against the noradrenaline 
concentrations and fit to a sigmoidal curve (wt-cam: black, n=7, EC50=1.04 µM; L75K-cam: red, n=11, 
EC50=0.22 µM). D: Individual measurements in unpatched cells stimulated with 100 µM NA were 
normalized to the maximal NA-mediated FRET response to compare off-kinetics (average±SEM; wt-cam: 
black, n=10; L75K-cam: red, n=7). E: Measurements of mutant- and wt-cam stimulated with 10 µM NA 
were normalized to the maximal FRET response prior to the depolarizing step (average±SEM; wt-cam: 
black, n=4; L75K-cam: red, n=6). 
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Introduction of the L75K mutant into α2A-AR-YFP resulted in a receptor construct 
unable to interact with arrestin in an arrestin FRET assay despite good plasma membrane 
localization. It was not investigated, however, whether the absence of a FRET increase 
upon stimulation with NA resulted from a lack of receptor phosphorylation by GRK2, 
failed translocation of arrestin to the plasma membrane, missing interaction between α2A-
AR-YFP and CFP-arrestin per se or any unspecific effect of depolarization for example on 
the orientation of the fluorophores towards one another. Introduction of a negative charge 
in the vicinity of D2.50 (A83D) into the α2A-AR-cam and –YFP resulted in receptor mutants 
which were not expressed in HEK 293 cells. 
Taken together, the left shift in concentration-response curve and slow deactivation 
kinetics seen in Figure 28B, D and E indicate an increase in affinity towards NA induced 
by the mutation of L75 to K75. Compensation of the shift in agonist affinity did not equal 
the degree of depolarization-induced receptor deactivation: Depolarization deactivated 
wild-type α2A-AR-cam during stimulation with 1 µM NA (Figure 29C (black trace), more 
than factor five-fold higher suggested by the concentration-response curve) to a greater 
extent than during stimulation of the α2A-AR-L75K-cam with 100 nM (Figure 28B, red 
trace). This suggests that the introduction of a countercharge near D2.50 altered voltage-
dependence of the construct and that D2.50 could supposedly be a residue of the voltage-
sensor of α2A-AR. This conclusion, however, needs to be strengthened by further 
experiments (7.2). 
6.4.2.4 An L75K/D79A α2A-AR-cam double mutant did not reverse voltage-
sensitivity  
As seen in the concentration-response curve and the analysis of deactivation kinetics, 
the replacement of leucine 75 by lysine increased the affinity for noradrenaline at the α2A-
AR and reduced voltage-dependence. If D2.50 were the voltage-sensor and caused a voltage-
dependent conformational change in the receptor by a movement of TM2 in one direction, 
we wondered whether an opposite charge would reverse the direction of TM movement 
and of voltage-dependence or would reduce voltage-dependence. Taking the α2A-AR-
L75K-cam as a template the additional D79A-mutation was inserted by site-directed 
mutagenesis (Figure 29A). Cells expressing the resulting receptor double mutant (α2A-AR-
L75K/D79A-cam) were stimulated with 1 µM NA and subjected to a depolarizing pulse to 
+60 mV (Figure 29B). Noradrenaline activated the mutant receptor resulting in an average 
ratio decrease of just above 1%. This agonist-induced FRET amplitude was slightly 
reduced during depolarization to +60 mV (Figure 29B). Comparison of conformational 
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changes induced by stimulation with 1 µM NA of wildtype-, L75K- and L75K/D79A-cam 
revealed large differences especially for the double mutant receptor construct which 
seemed restricted in its ability to undergo an activating conformational change upon NA-
stimulation (Figure 29C). Single mutation of leucine 75 hardly reduced the NA-induced 
FRET response compared to the wild-type α2A-AR-cam.  
 
Figure 29: Double mutation of the α2A-AR-cam: Insertion of K75 and charge removal by mutation of 
D79 to A79 
A: The schematic shows the double mutation compared to the wt-residues at positions 75 and 79. B: The 
transiently expressed L75K/D79A double mutant was activated with 1 µM NA and depolarized to +60 mV 
(average±SEM, n=3). C and D: Comparison of the depolarizing effect on transiently transfected wt-, L75K- 
and L75K/D79A-cam constructs activated with 1 µM NA. Normalization to the initial FRET values prior to 
NA application allows comparison of the degree of agonist-induced conformational change in the receptor 
molecules (C). For the comparison of depolarization-induced receptor inactivation the same data was 
normalized to the maximal NA-induced FRET response before the depolarizing step (D). Average±SEM; wt-
cam: black, n=3; L75K-cam: red, n=8; D79A/L75K-cam (data of B): green, n=3. 
Introduction of the two point mutations into α2A-AR-cam (α2A-AR-L75K/D79A-cam) 
reduced its activity, did not invert voltage-dependence but responded only poorly to 
depolarization. D2.50 seemed to be part of the voltage-sensor in α2A-AR among other yet 
unidentified residues. Whether these findings are transferable to other voltage-dependent 
GPCRs remains to be tested.   
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7 Discussion 
About 3% of all genes in the human genome encode for GPCRs (Takeda et al., 2002). 
They can be activated by small molecules, peptides, proteins or photons and transduce 
extracellular signals across the membrane into intracellular responses (Gether, 2000). 
Fairly recent findings showed that the activity of several Gi- and Gq-coupled GPCRs was 
sensitive to alterations in the membrane potential (Ben-Chaim et al., 2003; Martinez-Pinna 
et al., 2005, 2010; Sahlholm et al., 2008c, 2012; Rinne et al., 2013). Voltage-dependence 
has first been identified as altered agonist affinity at depolarization in radio-ligand binding 
experiments (Ben-Chaim et al., 2003). Alterations in the membrane potential were induced 
with buffers of different potassium concentration. A direct control of the membrane 
potential by voltage-clamp electrophysiology to measure Gi-mediated GIRK currents or 
acetylcholine-induced potassium currents (IKACh) in atrial myocytes to address voltage-
dependence of the corresponding receptors was an advantage compared to measurements 
that relied on altered potentials by different potassium concentrations (e.g. (Moreno-
Galindo et al., 2011; Navarro-Polanco et al., 2011; Sahlholm et al., 2012). However, 
inward rectification of GIRK channels has been shown to be altered in a concentration-
dependent manner (Hommers et al., 2003). Strong receptor activation led to a reduction in 
inward rectification. This indirect effect could be misinterpreted as a voltage-dependent 
reduction of receptor activity. The combination of patch-clamp electrophysiology and 
measurements of Ca2+-signals identified voltage-dependence of certain Gq-coupled 
receptors (Martinez-Pinna et al., 2004, 2005). Conclusions from these measurements 
involved statements of altered agonist efficacy due to changes in the membrane potential. 
However, these indirect measurements are unsuited for efficacy measurements as they are 
affected by receptor expression, coupling of effectors and amplification steps in the 
signaling cascade (Lohse et al., 2003). A suitable tool to directly measure the influence of 
membrane depolarization on agonist efficacy and/or affinity are fluorescence-based assays 
monitoring receptor conformational changes or direct receptor-effector interactions (Lohse 
et al., 2003; Rinne et al., 2013, 2015). Such a direct assay was applied to investigate 
depolarization-dependent conformational changes within the binding pocket of M2AChR 
using site-directed fluorescence labeling (Dekel et al., 2012).  
By means of different intramolecular and intermolecular FRET-based assays in 
combination with direct control of the membrane potential with patch-clamp 
electrophysiology led to the following key findings in this study: 1) The activity of the Gs-
coupled β1-AR and to a smaller extent of β2-AR is voltage-dependent. 2) This voltage-
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dependence was an intrinsic property of the two receptors and occurred within the 
physiological range of membrane potential. 3) Measurements of effectors of both β1-AR 
and β2-AR revealed transmission of the voltage-sensitivity to downstream signaling. 4) 
Stimulation of β1-AR with different ligands also showed an agonist-specific component of 
β1-AR voltage-sensitivity. 5) Most importantly, voltage-dependence was mainly mediated 
via a reduction in agonist efficacy during depolarization at β1-ARs activated by 
isoprenaline or adrenaline. A depolarization-induced reduction in agonist affinity 
contributed only to a minor extent to β1-AR voltage-dependence and appeared to be 
stronger for Adr than Iso.  
7.1 Voltage-dependence of adrenoceptors 
By means of a combination of FRET measurements and whole-cell patch-clamp in 
voltage-clamp mode voltage-dependence of Gs-coupled receptors β1-AR and β2-AR was 
determined (Birk et al., 2015). Even though the molecular mechanism by which the 
membrane potential induces a conformational change in the ligand binding pocket remains 
unclear, it could ultimately alter either agonist affinity, agonist efficacy or both. Voltage-
dependence of agonist binding has been measured for M1AChR, mGluR1, M2AChR and 
mGluR3. Depolarization increased the binding of the former two and decreased agonist 
binding of the latter two (Ben-Chaim et al., 2003; Ohana et al., 2006). I also intended to 
investigate voltage-dependent binding of [3H]-noradrenaline to α2A-AR expressed in 
Xenopus oocytes to directly show reduced noradrenaline affinity which has been 
demonstrated with the α2A-AR-cam (Rinne et al., 2013). In two sets of experiments specific 
binding could be detected at rest and at depolarization induced by high external K+ (Figure 
23). In one of the two experiments specific binding was significantly lower during 
depolarization whereas the other only showed a tendency towards reduced binding. Several 
problems occurred and made it difficult to interpret the data: Expression of α2A-AR was 
low in most batches of injected oocytes which resulted in low total binding of the radio-
ligand. Depolarization of cells using buffers of high K+-concentrations is also difficult. 
High external K+ might by itself influence GPCR activity as described for P2Y receptors 
(Pitt et al., 2005). In addition, noradrenaline affinity was reduced when the external 
solution was depleted of sodium indicating a sodium-dependence of noradrenaline binding 
to α2A-AR (unpublished data of Prof. Rinne and (Pihlavisto et al., 1998)). Although we 
think that binding of noradrenaline should be decreased during depolarization as indicated 
by the right-shift in the concentration-response curve measured for α2A-AR-cam, it was not 
possible to definitively show it in a ligand binding assay.  
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Alterations in agonist affinity were also apparent in the measurements of β1-AR and β2-
AR and α2A-AR. Stimulation of β1-AR with saturating concentrations of Iso or Adr 
reduced the depolarization effect on receptor activity and receptor-arrestin interaction 
indicating a depolarization-mediated decrease in agonist affinity (Figure 9, Figure 12E). 
Adr-stimulated cells showed higher sensitivity towards depolarization-induced receptor 
deactivation in non-saturating conditions and thereby a larger reduction of depolarization-
effect with increasing concentrations of agonist. Nevertheless, a reduced deactivating 
effect by depolarization remained during saturation with Iso, Adr and NA (Figure 9 and 
Figure 12E and F). Agonist affinity was therefore not the only target of voltage-
dependence in β1-AR. This finding was especially surprising for Adr because so far 
voltage-dependence of receptors stimulated by endogenous ligands has been attributed to 
alterations in agonist affinity (Navarro-Polanco et al., 2013; Rinne et al., 2013). Voltage-
dependence of β2-AR seemed to be purely mediated by a change in agonist affinity given 
that saturation of the receptor with either Iso or Adr prevented disruption of receptor-
arrestin interaction during depolarization (Figure 22). Depolarization-mediated reduction 
of α2A-AR-Arr3 interaction was abolished under saturation with NA whereas some 
reduction remained under saturation with Adr (Figure 24A). As described above reduction 
of NA affinity during depolarization at the α2A-AR was in line with earlier work (Rinne et 
al., 2013).  
Receptor number and coupling to effectors are tissue and cell type specific wherefore 
measurement of agonist efficacy should be direct through detection of receptor 
conformational changes. FRET-based intramolecular receptor fusion proteins are therefore 
an ideal tool to measure intrinsic efficacy (Lohse et al., 2003). A reduction in clonidine 
efficacy during depolarization has been directly demonstrated in this manner with the α2A-
AR-cam construct (Rinne et al., 2013). Reports on voltage-dependent alteration of agonist 
efficacy at the M2AChR activated by pilocarpine, the P2Y1 or the D2SR, however, were 
based on indirect efficacy measurements (Gurung et al., 2008; Navarro-Polanco et al., 
2011; Sahlholm et al., 2011). Using FRET assays measuring β1-AR activation as well as 
assays detecting receptor-effector interaction the depolarizing effect on agonist efficacy 
was analyzed directly. Deactivation kinetics in all three assays showed a substantial 
acceleration (up to 100-fold in Iso-stimulated receptors at the receptor level) during 
depolarization compared to deactivation by agonist withdrawal. Interestingly, although Iso 
and Adr exhibited agonist-specificity with regard to voltage-dependent reduction in agonist 
affinity, deactivation kinetics during depolarization yielded a comparable degree of 
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depolarization-mediated reduction in agonist efficacy (Figure 14B and D). The differences 
between deactivation kinetics by depolarization and by agonist washout exceeded the only 
minor reduction in agonist affinity for both Iso and Adr. Therefore alterations in efficacy 
seem to mainly underlie voltage-dependence of Iso- and Adr-stimulated β1-AR. This 
conclusion was also corroborated by a classical concentration-response experiment of β1-
AR-arrestin 3 interaction induced by isoprenaline: Whereas the about two-fold right-shift 
of the curve at depolarization relative to the curve at rest, representing a reduction in Iso-
affinity, did not reach statistical significance, the maximal FRET response at 
depolarization was significantly smaller, which reflects a reduction in efficacy (Figure 
16B). For Adr the right-shift in a concentration-response curve at depolarization would be 
expected to be more pronounced and the reduction in the maximal FRET response similar 
or less pronounced as seen for Iso. It would be interesting to do similar measurement with 
Adr to see whether these predictions would be confirmed. 
Voltage-dependence of GPCRs has been suggested to be an intrinsic property of the 
receptor molecule. Strong evidence supporting this hypothesis arose from measurements of 
gating charges in M1AChR and M2AChR (Ben-Chaim et al., 2006; Navarro-Polanco et al., 
2013). Charge movement resulting in currents analogous to gating currents of voltage-
gated ion channels also correlated well with voltage-dependent agonist binding in 
M2AChR (Ben-Chaim et al., 2006). Additional evidence for an intrinsic voltage-
dependence of the receptor molecule was provided by FRET-based measurements of an 
intramolecular α2A-AR fusion protein (α2A-AR-cam) (Rinne et al., 2013). The activation-
induced movement of transmembrane helices relative to each other which is transferred to 
intracellular loop 3 (IL3) and the c-terminus, enabled FRET measurements with these 
fusion proteins as they carry FRET donor and acceptor in the c-terminus and IL3 or vice 
versa (Lohse et al., 2003; Vilardaga et al., 2003). With the α2A-AR-cam a depolarization-
mediated receptor deactivation was monitored which was reversible upon repolarization 
(Rinne et al., 2013). FRET response-VM relations of NA-activated α2A-AR-cam in the 
presence and absence of PTX overlay nicely which indicated that voltage-dependence was 
an intrinsic property of the receptor and was independent of its interaction with Gi proteins 
(Rinne et al., 2013). This is also corroborated by the fact that insertion of a bulky 
fluorophore into the third intracellular loop greatly reduces G protein coupling to these 
intramolecular FRET-based receptors (Vilardaga et al., 2003; Hoffmann et al., 2005). With 
FRET-based fusion proteins of β1-AR and β2-AR cloned analogously to α2A-AR-cam 
(Rochais et al., 2007; Ahles et al., 2011), depolarization-induced receptor deactivation was 
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nicely visible for the former and also present but less pronounced in the later (Figure 8 and 
Figure 21A). Both Iso- and Adr-stimulated cells expressing the β1-AR-sensor showed 
reversible receptor deactivation during depolarization. These data confirmed the intrinsic 
voltage-dependence of the Gs protein-coupled β1-AR and β2-AR. As both β1-AR- and β2-
AR-sensors closely resemble wild-type-like properties (Rochais et al., 2007; Ahles et al., 
2011), these findings can also be extrapolated to the wild-type β1-AR and β2-AR. 
Real-time live-cell FRET measurements are well suited to investigate receptor 
conformational changes as described above but also to monitor protein interactions along 
the signaling axes downstream of the receptor molecule (Lohse et al., 2012). FRET assays 
monitoring receptor-effector interaction and G protein activation demonstrated that 
voltage-dependence was transmitted from the receptor molecule to downstream effectors. 
This is a necessity for the voltage-dependence to be of physiological importance as 
alterations in downstream signaling result in altered cellular responses to extracellular 
stimuli. For β1-AR both agonist-induced G protein-receptor interaction as well as G protein 
activation were reduced by depolarization of the plasma membrane (Figure 10B, C and 
Figure 11B-C). Arrestin signaling was also decreased during depolarization indicated by a 
reduction of β1-AR-arrestin 3 interaction (Figure 12). Interaction of arrestin 3 with the β2-
AR induced by a non-saturating Iso concentration was also decreased during 
depolarization (Figure 22A). Stimulation with a saturating concentration of Iso and Adr or 
NA prevented a depolarizing effect on the interaction of arrestin 3 with β2-AR or α2A-AR, 
respectively, whereas the interaction of α2A-AR and arrestin 3 induced by a saturating 
concentration of Adr was still reduced by depolarization (Figure 22B and Figure 24A). 
Voltage-dependence of downstream signaling is in line with measurements of altered 
GIRK currents transmitted from voltage-dependent M2AChR,, α2A-AR, mGluR3, D2, H3, 
H4, of changes in Cl- currents of Ca2+-dependent chloride channels through voltage-
dependent M1AChRs or of differences in Ca2+ signaling due to voltage-dependence of 
P2Y1, 5-HT2A, TXA2 or LPA receptors (Ben-Chaim et al., 2003; Martinez-Pinna et al., 
2005, 2010; Ohana et al., 2006; Sahlholm et al., 2008c, 2012; Rinne et al., 2013). Another 
indication that voltage-dependence of β1-AR could be of physiological relevance is that it 
occurred within the range of physiological membrane potential (Figure 13). Similar 
measurements at the α2A-AR yielded a half maximal effective potential of -20 mV (Rinne 
et al., 2013) compared to -27 mV and -28 mV for Adr- and Iso-stimulated β1-AR, 
respectively. The half-point of maximal charge movement was slightly more negative in 
M1AChR (V50=-53 mV (Rinne et al., 2015)) and M2AChR (V50=-44 mV (Ben-Chaim et 
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al., 2006); V50=-67 mV (Navarro-Polanco et al., 2011)). Number of charges moved across 
the membrane (z-values) of 0.49 e0 determined for Adr-stimulated β1-AR was comparable 
to the values calculated for M1AChR (z=0.76 e0 (Rinne et al., 2015)), M2AChR 
(z=0.55/0.85 e0 (Ben-Chaim et al., 2006; Navarro-Polanco et al., 2011)) and α2A-AR 
(z=0.5 e0 (Rinne et al., 2013)). A slightly shallower VM-FRET response relation of Iso-
stimulated cells resulted in a z-score of 0.36 e0. A third important observation pointing 
towards physiological relevance was that voltage-induced deactivation of β1-AR occurred 
within very fast time scales (Figure 14). The voltage-dependent regulation of agonist 
efficacy could lead to very fast alterations of receptor signaling because the time-limiting 
step of agonist dissociation from the receptor is bypassed. Downstream signaling could 
therefore be altered by the membrane potential even in the presence of agonists. Fast 
kinetics are consistent with fast voltage-dependent changes in M2AChR for which it was 
suggested that even a single action potential would suffice to induce fast gating charges 
(Ben-Chaim et al., 2006). An indication of the physiological importance of voltage-
dependent regulation of receptor activity was suggested by studies on Gi protein-coupled 
presynaptic M2AChR autoreceptors which seemed to control kinetics of neurotransmitter 
release at murine neuromuscular junctions (Kupchik et al., 2011). However, to finally 
prove a direct involvement of voltage-dependent M2AChR in the control of vesicle fusion 
and transmitter release could only derive from measurements with mutant M2AChR 
lacking voltage-dependence.  
The differential contribution of altered affinity of NA and Adr at α2A-ARs also indicated 
an agonist-specific component of α2A-AR voltage-dependence. This was also true for Adr 
and Iso at the β1-AR but especially obvious during stimulation with the partial agonist 
dopamine (Figure 20). Very recently it has been shown for muscarinic receptors that the 
mode of agonist binding would determine the direction of voltage-dependence (Rinne et 
al., 2015). An asparagine (N6.52) in TM6 was crucial for the effect of voltage changes on 
the signal and its mutation to glutamine was able to reverse the voltage-dependent effect. 
Agonist orientation towards TM6 correlated with a decrease in receptor activity during 
depolarization whereas orientation towards TM3 (particularly D3.32) correlated with an 
increased activity during depolarization. An interaction of the β-OH-group present in the 
catecholamines Adr, NA and Iso with N6.55 was suggested based on modeled Iso binding to 
β2-AR (Wieland et al., 1996). However, more recent dockings of Iso to β1-AR or β2-AR 
rather proposed an interaction of N6.55 with the cathechol meta-OH-group and an 
interaction of the β-OH-group with the highly conserved D3.32 (Katritch et al., 2009; Warne 
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et al., 2011). Dopamine lacks the β-OH-group altering the interaction with D3.32 and 
dopamine does not interact with TM6. This could cause a different binding mode within 
the binding pocket of β1-AR and could therefore result in the opposite voltage-dependent 
behavior of dopamine-stimulated β1-AR. Although the β-OH-group is also absent in 
dobutamine, the binding mode to β1-AR includes H-bonding between N6.55 and the catechol 
meta-OH group (Warne et al., 2011) thereby probably causing a voltage-dependent 
behavior more similar to Iso than to dopamine. Agonist-specificity is not limited to the 
adrenoceptors investigated in this study but was also reported for example for several 
(clinically used) agonists at the D2SR (Sahlholm et al., 2008b, 2011), for the α2A-AR 
(Rinne et al., 2013) and for muscarinic receptors (Navarro-Polanco et al., 2011; Rinne et 
al., 2015). 
To enable Förster resonance energy transfer between the donor and acceptor 
fluorophore, their emission and absorption spectra, respectively, need to overlap, the 
distance to one another must be 10 nM or less and the orientation of the transition dipoles 
should ideally be parallel (Förster, 1948; Miyawaki, 2011; Lohse et al., 2012). A 
combination of FRET and whole-cell patch clamp technique enabled us to directly set the 
membrane potential to any desired value. Compared to a change in membrane potential by 
external buffers of high potassium concentrations this method is independent of the 
expression of potassium conducting channels and thereby favorable on a single cell level. 
Furthermore, as described before, elevation of the extracellular K+-concentration was 
shown to influence GPCR activity independently of the rise in membrane potential and 
should therefore be avoided (Pitt et al., 2005). It was important to make sure that 
depolarization-induced alterations in the agonist-evoked FRET response were the result of 
a specific deactivating conformational change or disruption of receptor-effector interaction. 
Strong depolarization could also change the energy transfer signal unspecifically via a 
change in dipole orientation or in acceptor quantum yield. However, evidence arguing in 
favor of a specific effect of depolarization on receptor conformation and receptor-effector 
interaction was the following: 1) Depolarization did not change the initial FRET signal of 
the β1-AR-sensor in the absence of ligands. It only reduced the agonist-induced FRET 
response. 2) The effect of depolarization on agonist-evoked FRET responses was similar in 
amplitude for three different FRET assays even though 3) the direction of agonist-induced 
FRET amplitudes was opposed in receptor-FRET compared to the interaction assays.  
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7.2 Investigating the mechanism of voltage-sensing 
Despite an increasing number of publications about voltage-sensitive GPCRs the 
mechanism underlying voltage-dependence has not yet been identified. In the attempt to 
identify residues involved in voltage-sensing amino acids of α2A-AR were mutated by site-
directed mutagenesis in this study. Most mutations did not alter voltage-dependence, 
however, D2.50could be a part of the voltage-sensor in α2A-AR. 
In the first years it seemed that a receptor’s preferred G protein subtype would 
determine whether depolarization deactivated a receptor or enhanced its activation. This 
was based on the observation that Gi-coupled receptors like M2AChR or D2 were 
deactivated whereas activity of Gq-coupled receptors like M1AChR or P2Y1R increased 
during depolarization (summarized in (Mahaut-Smith et al., 2008)). An exchange of 
intracellular loop three (IL3), the main G protein coupling part of M1AChR and M2AChR, 
between the two receptors reversed direction of voltage-dependence during ACh 
stimulation. Therefore a mechanism was suggested in which voltage-dependent alteration 
in receptor activity was induced via altered G protein binding which in turn led to 
conformational rearrangements in the orthosteric binding pocket. However, gating currents 
in these chimeric constructs remained similar to wild-type M1AChR and M2AChR. In 
addition stimulation of M2AChR by two different ligands, ACh and pilocarpine, led to 
opposing depolarization effects (Navarro-Polanco et al., 2011). These findings suggested 
that IL3 rather functions as an effector of voltage-sensor movement than acting as a 
voltage-sensor itself. It is now believed that voltage-induced conformational changes 
directly act on the orthosteric binding site (Ben-Chaim et al., 2006; Bezanilla, 2008; 
Navarro-Polanco et al., 2011). As described above, treatment of the α2A-AR with PTX did 
not alter depolarization-induced receptor deactivation which also supports the hypothesis 
of a G protein-independent mechanism underlying voltage-dependence.  
A current task in the research field of GPCR voltage-dependence is the identification of 
a voltage-sensor which detects changes in the membrane potential and translates these 
changes into conformational changes in the orthosteric binding site and the receptor 
molecule itself. A possible voltage-sensor could be composed of charged amino acids 
which would move through the electrical field upon membrane potential changes and 
which is how voltage-gated ion channel react to different polarization of the membrane. 
However, sequence analysis showed that a similar structure to voltage-sensors of voltage-
gated ion channels does not exist in GPCRs (Bezanilla, 2008). Numbers of charges moved 
across the membrane of z=0.36-0.85 e0 measured for β1-AR, α2A-AR, M1AChR and 
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M2AChR (Ben-Chaim et al., 2006; Navarro-Polanco et al., 2011; Rinne et al., 2013, 2015; 
Birk et al., 2015) suggest that either one charged residue moves across half the membrane 
or a number of charged residues undergo small movements. The former is rather unlikely 
as a movement of one amino acid across half the membrane would cause a large movement 
of its TM domain which would certainly hamper receptor function. The membrane 
potential in GPCRs is therefore presumably sensed by more than one residue.  
In fact only few charged amino acids reside within the TM domains were the electrical 
field is strongest. Mutation of a charged lysine in the extracellular half of TM3 did not alter 
voltage-dependence of α2A-AR (Figure 27). Mutation of S5.46 involved in agonist binding 
(Figure 26) most likely did not help to identify a voltage-sensor but would need to be 
investigated in more detail before a conclusive evaluation can be done.  
Alterations in the membrane potential could also be transmitted via the movement of 
dipoles through the electrical field. Another possibility of sensing the membrane potential 
is by free ions associated in cavities within the receptor molecules (Bezanilla, 2008). As 
crystal structures of β1-AR and A2AR identified a sodium ion binding site within the TM 
bundle, mutation of the coordinating residues D2.50 or S3.39 seemed reasonable (Liu et al., 
2012; Miller-Gallacher et al., 2014). Mutation of the corresponding aspartic acid in 
M2AChR to alanine resulted in a construct with low membrane expression and no 
conclusive results on voltage-dependence of this mutant could be obtained (Navarro-
Polanco et al., 2011). Introduction of the D2.50A mutation into α2A-AR greatly reduced 
agonist affinity and a depolarization-induced receptor deactivation was not detectable 
(unpublished data of Prof. Rinne). Via the introduction of a positive counter charge in the 
direct vicinity of the aspartic acid we hoped to create a receptor mutant lacking voltage-
dependence but with otherwise wild-type-like properties (Figure 28). The resulting α2A-
AR-L75K-cam increased agonist affinity but showed reduced voltage-dependence 
compared to wild-type α2A-AR stimulated with noradrenaline. This was not only due to the 
higher affinity of the mutant and a resulting left-shift of voltage-dependence as wild-type 
α2A-AR-cam showed a stronger deactivation during depolarization when activated with a 
noradrenaline concentration which balanced the differences in agonist affinity. 
Combination of both mutations to α2A-AR-L75K/D79A-cam generated a mutant of little 
agonist-evoked FRET responses and some depolarization-dependent deactivation. If D2.50 
were the only residue involved in voltage-sensing, one would expect a reversed voltage-
dependence of this double mutant due to the removal of a negative and insertion of a 
positive charge, but was not detected in the FRET measurements. Nevertheless, D2.50 
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seemed to be involved in voltage-sensing of the α2A-AR but the exact course of voltage-
dependence of this receptor mutant needs to be investigated in more detail in the future. A 
shift in the Boltzmann curve or an alteration of its steepness would be hints on altered 
voltage-sensitivity of the mutant and an involvement of D2.50 in the voltage-sensor.  
 
In summary I was able to demonstrate, for the first time, that also the activity of Gs-
coupled receptors displays voltage-dependence. Voltage-dependence of β1-AR is mainly 
mediated by an alteration in efficacy of both Adr and Iso and occurs within the time scale 
of cardiac action potentials. The activity of β1-AR could therefore be modulated even 
without dissociation of the endogenous ligand adrenaline from the receptor. Rhythmic 
alterations in the membrane potential of myocytes occurring physiologically could 
reversibly deactivate the receptors resulting in reduced receptor desensitization via a 
reduced interaction of receptors and arrestins.  
The highly conserved aspartic acid in TM2 of Rhodopsin-family GPCRs could be 
involved in voltage-sensing in the α2A-AR. However, its contribution needs to be verified 
in further experiments. Similar mutations in other receptors would be necessary to test 
whether this involvement is an α2A-AR-specific phenomenon or whether D2.50 is part of a 
common GPCR voltage-sensor. Besides D2.50 the search for other components of a GPCR 
voltage-sensor which directly react to changes in the membrane potential is still ongoing.  
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